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ABSTRACT 
Carbocyanine dyes are a class of organic compounds that possess two nitrogen containing het-
erocycles that act as electron donors and acceptors connected by a conjugated methine bridge. This 
thesis will present the synthetic methodology of symmetrical and unsymmetrical trimethine cyanine 
dyes in three chapters. The first chapter is a review on the synthesis and application of unsymmetric cy-
anine dyes. The second will describe the synthesis of unsymmetrical trimethine cyanine dyes and how 
their optical properties differ from symmetrical dyes. The third chapter will not only discuss the synthet-
ic procedure for synthesis of symmetrical trimethine cyanine dyes, but also will show how varying the N-
alkyl substituents and hydrophobicity of the heterocycles affects the dyes interaction with and ability to 
be used as inhibitors for protein arginine methyltransferases (PRMTs). Several synthesized compounds 
have displayed lower IC50 values for the inhibition of PRMT1 and PRMT5 comparable to that of current 
inhibitors. 
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1     SYNTHESIS AND APPLICATIONS OF UNSYMMETRICAL CYANINE DYES, A REVIEW  
1.1 Introduction to Cyanine Dyes 
In 1856, C. H. G. Williams synthesized the first cyanine dye by heating quinoline with N-amyl 
lepidinium iodide in ammonia. The compound produced displayed a “magnificent blue color,” thus the 
Latin word cyanos, meaning blue, provided the general cyanine dye name.1 This vast class of dyes shows 
absorption that covers a wider range of the electronic spectrum, from the ultraviolet to the infrared, 
than any other class of dyes. Due to their extreme sensitivity to light, the inconceivable value of cyanine 
dyes was not discovered until almost 20 years later when H. W. Vogel used them to increase sensitivity 
of the photographic plate.2 Since then cyanine dyes have been used in an incredible amount of applica-
tions including but not limited to laser printing,3 pH sensors,4 fluorescence imaging in vivo,5 data stor-
age,6 labels for nucleic acid detection,7-9 and medicine.10 
Cyanine dyes are distinguished from other dyes in that they possess two nitrogen containing 
heterocycles that are connected by a conjugated methine bridge as shown by the general structure in 
Figure 1.11-14 
 
Figure 1. General Structure of Cyanine Dyes 
Their names depend on the how many methine groups are found in the bridge connecting the 
two heterocycles. Dye 1 represents the general structure of cyanine dyes. Dyes containing n = 0, 1, 2, 
and 3, are classified as mono-, tri-, penta-, and hepta-, respectively. There are multiple well described 
routes to synthesis of monomethine and trimethine cyanines,15 but pentamethine and heptamethine 
2 
cyanines have one general route. This route is through the condensation of methylsubstituted quater-
nized heterocyclic compounds with an α,ω dialdehyde or equivalent.13,15-18 
Their narrow absorption bands and high extinction coefficients are important properties that 
have allowed them to be used in various applications over the last 140 years. Monomethine and trime-
thine cyanines typically absorb in the 500-600 nm range of the electronic spectrum and the addition of 
each double bond to the methine chain causes a bathochromic shift of about 100 nm resulting in ab-
sorption of 600-700 nm for pentamethine, and 700-800 nm for heptamethine cyanines, well into the 
infrared region.  
 
Figure 2. Electromagnetic Spectrum 
 
 One synthesis route for unsymmetrical dyes is to condense two different quaternary ammonium 
salts with the polymethine chain linker in one pot. This route involves a difficult separation of two sym-
metrical dyes from the unsymmetrical dye which are all very similar. There are numerous synthetic 
routes for the synthesis of unsymmetrical monomethine cyanine dyes, but only two main routes for un-
symmetrical trimethine, pentamethine, and heptamethine cyanines. These routes are known as the al-
dehyde and hemicyanine methods and have less difficult purifications than the one pot method conden-
sation of two salts with linker. In addition a thioether method can be used to synthesize trimethine cya-
nines with a methyl group at the meso-carbon. This chapter will explore the synthesis of these unsym-
metrical dyes with less difficult purification. 
3 
1.2 Synthesis of Monomethine Cyanine Dyes 
Monomethine cyanine dyes typically absorb in the visible region. This is the most common type 
of unsymmetrical cyanine dye as they are the easiest type of unsymmetrical cyanine dye to synthesize. 
The majority of monomethine dyes are unsymmetrical as the synthesis is based on the condensation of 
two quaternary ammonium salts and there is no methine linker used. Unsymmetrical monomethine cy-
anines are the best non-covalent binding nucleic acid labels due to their very high binding constants, 
large molar absorptivities and quantum yields, and the generation of high fluorescence signals upon 
binding.19 Two commercially available unsymmetrical monomethine cyanines based on the oxazole yel-
low structure, YO-PRO-1 and YOYO-1 shown in Figure 3, are among the most popular intercalating dyes 
and have recently been used for DNA and chromatin imaging with super-resolution fluorescence micros-
copy.20 
 
Figure 3. Commercially Available Unsymmetrical Monomethine Cyanine Dyes 
One synthesis route to monomethine cyanines is through the heating of sulfobetaines derived 
from N-alkylheterocyclic compounds and a quaternary salt of 2- or 4-methyl compounds under basic 
conditions as shown in Equation 1.21 
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Equation 1. Synthesis of Monomethine Cyanine Dyes Utilizing Sulfobetaines
21
 
A second approach to the synthesis of monocyanines involves the reaction of a ketone such as 
7-hydroxy-4-methyl(H)coumarin with a 2- or 4-methyl quaternary salt in the presence of a piperidine 
catalyst as shown in Equation 2.22 
+
N
I-
5a: R = H, X = O
5b: R = H, X = O
5c: R = Me, X = NH
5d: R = Me, X = NH
XHO O
R
Piperidine
EtOH XHO
R
N
I-
5 6 7
(2)
7a: R = H, X = O
7b: R = H, X = O
7c: R = Me, X = NH
7d: R = Me, X = NH  
Equation 2. Synthesis of Monomethine Cyanine Dyes Utilizing Ketones
22
 
These compounds 7a-d are effective antibiotics against Bacillus stearothermophillus, Serratia 
species, and Pseudomonas species; however these novel dyes are ineffective toward fungal infections. 
The addition of the methyl to compounds 7c and 7d has been shown to increase antimicrobial activity 
compared to other compounds tested.22 
Previously the synthesis of monomethine cyanine dyes was reported in low yields, but recently 
Yi Le Fu et al. have described a simple microwave assisted and solvent free preparation using the thi-
oether method, a common approach to the synthesis of monomethine dyes.23 This process has in-
creased yields from 21% in 2 hours using traditional approaches to 59% in 18 min with the use of 252 W 
microwave radiation (Equation 3). 
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Equation 3. Synthesis of Monomethine Cyanine Dyes Utilizing Thioethers
23
 
The thioether method used for microwave synthesis was modified by Deligiorev et al. to synthe-
size a neutral monomethine 13 cyanine using an environmentally friendly melt method as shown in 
Equation 4.24 
 
Equation 4. Synthesis of Monomethine Cyanine Dyes Utilizing a Melt Method
24
 
El-Shishtawy et al. employed the thioether method to synthesize a monomethine cyanine dye 
16 used for the detection of calf-thymus DNA in aqueous solution as shown in Equation 5. As is common 
with many monomethine cyanines, this dye binds by intercalation and shows enhanced fluorescence 
upon binding.25 
 
Equation 5. Synthesis of Cyanine Dyes Utilizing Thioether Method
25
 
 An example of the reaction performed by Zanotti et al. using the thioether method to condense 
benzoxazole salts with benzothiazole and pyridinium salts to form monomethine dyes is shown in Equa-
tion 6. These dyes bind both yeast cell surface-displayed and soluble single-chain variable antibody 
fragments with nanomolar Kd values.
26 
6 
 
Equation 6. Synthesis of Cyanine Dye Binding Yeast Cell Surfaces
26
 
1.3 Synthesis of Tri-, Penta-, and Hepta-methine Cyanine Dyes 
The synthesis of tri-, penta-, and hepta-methine unsymmetrical cyanine dyes is performed 
through two main synthesis routes that are very similar. The aldehyde method involves the addition of a 
short chain with an aldehyde to a quaternary ammonium salt for reaction with a second salt to form un-
symmetrical dye. The hemicyanine method involves the synthesis of hemicyanine or “half dye” and its 
purification from any dye that forms. Hemicyanines are sometimes hydrolyzed into aldehydes for reac-
tion with the second salt to prevent symmetrical dye formation. The thioether method that has been 
used for synthesis of monomethine dyes has been modified to synthesize trimethine cyanines contain-
ing a meso-methyl group and could be utilized for unsymmetrical synthesis. 
1.3.1 Thioether Method for Trimethine Cyanine Dyes 
Although uncommon, the thioether that is used for monomethine dye synthesis can also be 
used for trimethine cyanine dyes. This route has been described by Brooker et al. for the synthesis of 
symmetrical trimethine cyanine dyes with a methyl substitution on the meso carbon,27 but could also be 
used to form unsymmetrical dyes as shown in Equation 8.  
 
Equation 7. Synthesis of Trimethine Cyanine Dyes Utilizing Thioether Method 
7 
 
In addition the meso methyl group in 22 can be condensed with aldehydes, such as 2,3,6,7-
tetrahydrobenzo[ij]quinolizine-9-carboxaldehyde 23 under basic conditions to furnish meso-substituted 
unsymmetrical trimethine cyanines as shown in Equation 9. 
N
S
I-
N
S
1) Piperidine, EtOH
2) NaI, MeOH
N
CHO
N
S
I- N
S
N
22 24
(9)
23
 
Equation 8. Synthesis of Meso-substituted Trimethine Cyanine Dyes
27
 
1.3.2 The Aldehyde Method 
The aldehyde method has been used for the synthesis of trimethine, pentamethine and hep-
tamethine cyanine dyes. The process involves the addition of a short chain with a terminal aldehyde to 
the quaternary ammonium salt which can then be reacted with a second salt to form unsymmetrical 
dye. The formation of the aldehyde is the key step in the synthesis of unsymmetrical cyanine dyes using 
this method. A pure aldehyde will allow only one product to be formed during the dye condensation 
making for much easier purification. There are a few different versions for trimethine and pentamethine 
cyanines, but only one for heptamethine. 
For trimethine cyanine dyes, the most common version of the aldehyde method involves the use 
of a Vilsmeier reagent formed through the reaction of phosphorous oxychloride with N,N-
dimethylformamide at 0°C. This aldehyde is then reacted with a quaternary ammonium salt to form 
dye.28-30 
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Scheme 1. Synthesis of Unsymmetrical Trimethine Cyanine Dyes Utilizing the Aldehyde Method 
Another aldehyde method for trimethine cyanine dyes was described by Meguellati, et al. In this 
method, the quaternary ammonium salt 29 is first converted to a Fischer base 30 under basic conditions. 
The Fischer base 30 is then reacted with (chloromethylene)dimethylammonium chloride in dichloro-
methane followed by dissolution in aqueous K2CO3 solution to form the aldehyde 31 as seen in Scheme 
2. The ester was cleaved to a carboxylic acid for attachment of 34 to one strand of peptide nucleic acid 
(PNA) while the Fischer base 32 was attached to another strand of PNA. When the two strands com-
bined to form G-quadruplex DNA dye 33 formed and fluorescence could be detected.31 
 
Scheme 2. Trimethine Cyanine Dye Synthesized Upon Formation of G-Quadruplex DNA
31
 
9 
One of the most common purposes for the synthesis of unsymmetric trimethine cyanine dyes is 
for conjugation to one side of the dye.  Hua et al. have utilized the aldehyde method to synthesize nu-
merous trimethine cyanine dyes for use in solar cells.32,33 Through Sonogashira coupling, the halogen on 
the aldehyde 35 is converted to a trimethylsilane protected alkyne 36. This alkyne is then deprotected 
 
Scheme 3. Synthesis of Starburst-Triphenylamine and Fluoranthene- based Trimethine Cyanine 
Dyes
32,33
 
10 
and a second Sonogashira coupling reaction is performed to attach a polycyclic aromatic system. The 
dye 39 is then formed by condensation of the aldehyde 38 with a quaternary ammonium salt to form a 
dye sensitized solar cell. In 2009, starburst triphenylamine-based dyes 39a were synthesized for use as 
quasi-solid-state dye-sensitized solar cells.32 A starburst triphenylamine group was added as an electron 
donor through “click chemistry” improving photovoltaic performance. In addition, this group may inhibit 
aggregation, thereby increasing stability of the solar cells.32,34 The same chemistry, shown in Scheme 3, 
was utilized to synthesize fluoranthene-based cyanine dyes 39b.33 
1.3.2.1 Synthesis of Penta- and Hepta-methine Cyanine Dyes Using the Aldehyde Method 
Pentamethine cyanines typically absorb in the visible to near infrared region and are usually 
blue in color. The aldehyde methods for pentamethine cyanine dyes are similar to those of trimethine 
cyanines. One route, described by Peng et al. is to react quaternary ammonium salt 42 with 1,1,3,3-
tetrethoxypropane 43 in the presence of hydrochloric acid to form aldehyde 44 as shown in Scheme 4. 
This aldehyde 44 was synthesized for the purpose of imaging cellular viscosity and shows a 10-fold fluo-
rescence increase in glycerol compared to ethanol.35 
 
Scheme 4. Synthesis of Unsymmetric Pentamethine Cyanine Dyes Utilizing the Tetraethoxypropane 
Aldehyde Method
35
 
Briks et al. have described aldehyde methods for pentamethine and heptamethine that are simi-
lar to the formation of a Vilsmeier reagent for trimethine cyanine dyes using chemicals analogous to 
11 
DMF but with longer chains. A dimethylamino derivative of the quaternary ammonium salt 47a and 47b 
is formed by reaction of the salt with 3,3-dimethylaminoacrolein and 1-(dimethylamino)-5-formyl-1,3-
butadiene for pentamethine and heptamethine, respectively. The dimethylamino derivative 47 is then 
converted to an aldehyde 48 in a sodium hydroxide solution as shown in Scheme 5.36 Dyes 49a and 49b 
are then formed by condensing aldehydes 48a and 48b with a second salt in acetic anhydride to form 
penta- and hepta-methine cyanines respectively. 
 
Scheme 5. Synthesis of Unsymmetrical Penta- and Hepta- Methine Cyanine Dyes Utilizing the Alde-
hyde Method
36
 
1.3.3 Hemicyanine Method 
Another process used to synthesize tri-, penta- and hepta-methine cyanine dyes is the hemicya-
nine method. This process is much like the one used to synthesize symmetrical cyanines dyes, except 
that the reaction is peformed at a lower temperature, for a shorter time, and a different ratio of salt to 
reagent is used. Synthesis of symmetrical dyes is carried out in one step where the quaternary ammoni-
12 
um salt is used in a 2:1 ratio to the linker which is N,N-diphenylformamidine, malonaldehyde dianil hy-
drochloride or glutacondianil hydrochloride for tri-, penta- and hepta-methine cyanines respectively. For 
unsymmetrical cyanine dyes, a multistep process beginning with the reaction of quaternary ammonium 
salt with linker in a 1:1 ratio is carried out. This key step forms a hemicyanine or “half dye”. The problem 
with this method is preventing the formation of dye which is usually accomplished by carrying out the 
first step for a short period of time at lower temperatures than what are used for dye formation. Follow-
ing this procedure the trimethine cyanine dye 52 was synthesized in 50% yield as described in Scheme 
6.28 
Gerowska et al. utilized this process to synthesize unsymmetric trimethine cyanines with a halo-
gen on one side. As shown previously in Scheme 3, through Sonogashira coupling, the halogen was con-
verted to a triple bond for click labeling of azide nucleotides. Click labeled probes such as the one 
formed from dye 52 have been shown to perform better than probes labeled with esters of cyanine 
dyes, possibly due to the shorter linker between the dye and DNA.28 
 
Scheme 6. Synthesis of Unsymmetric Trimethine Cyanine Dyes Utilizing Hemicyanine Method
28
 
 Ge et al. employed the hemicyanine method to synthesize a number of unsymmetric trimethine 
cyanine dyes 53a-d containing both benzoxazole and benzothiazole groups, seen in Figure 4, and show-
ing in vitro antiprotozoal activity against P. falciparum and T. cruzi. Symmetric dyes containing only ben-
zoxazole groups were not as active against the protozoa revealing that the benzothiazole moieties are 
important for antiprotozoal activity.29 
13 
 
Figure 4. Unsymmetric Trimethine Cyanine Dyes Showing Antiprotozoal Activity
29
 
 Song et al. performed the hemicyanine method to design dyes 56 containing one carboxylic acid 
group for bioconjugation as shown in Scheme 7. The carboxylic acid was then converted to the active 
NHS ester for protein labeling on bovine serum albumin (BSA). These novel unsymmetric cyanines were 
shown to have better labeling performance due to the hydrophobic groups on one end and hydrophilic 
sulfo-groups on the other end.30 
 
Scheme 7. Synthesis of Unsymmetric Trimethine Cyanine Dye for Bovine Serum Albumin Labeling
30
 
Pentamethine and heptamethine cyanines undergo the hemicyanine method similarly to trime-
thine cyanines. Rather than N,N-diphenylformamide, malonaldehyde dianil hydrochloride and glu-
tacondianil hydrochloride are used for the formation of pentamethine and heptamethine hemicyanines, 
respectively, as shown in Scheme 8. Jung et al. synthesized pentamethine dye 59a. This dye was then 
activated with N-hydroxysuccinamide to form the NHS activated dye to be used for difference gel elec-
trophoresis and found it to be indistinguishable from commercially available dyes used for this purpose 
and stable in N,N-dimethylformamide for years.37 
14 
 
Scheme 8. Synthesis of Unsymmetrical Penta- and Hepta- methine Cyanine Dyes Utilizing the Hemicy-
anine Method
37
 
  While synthesis of unsymmetric trimethine cyanine dyes is becoming more prevalent, the syn-
thesis of unsymmetric penta- and hepta-methine cyanine dyes is still uncommon, particularly heptame-
thine cyanines. Wang et al. utilized the hemicyanine method to synthesize a series of pentamethine cy-
anine dyes (Scheme 9) for BSA labeling similar to the dyes 56 synthesized by Song et al. for the same 
purpose.38 In this preparation quaternary ammonium salt 54 was refluxed with malonaldehyde dianil 
hydrochloride in a mixture of acetic anhydride and acetic acid. After purification by column chromatog-
raphy, the hemicyanine intermediate 60 was heated with a second quaternary ammonium salt at 120°C 
for 40 min. The dyes 61a-c were then purified by reverse phase column chromatography using a metha-
nol/water mixture as the eluent. 
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Scheme 9. Synthesis of Pentamethine Cyanine Dyes for Bovine Serum Albumin Labeling
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1.3.4 Microwave Assisted Solid-Phase Synthesis 
As microwave synthesis becomes more popular due to the ability to avoid time-consuming reac-
tion steps and increase purity.39-42 Lopalco et al. designed a solid-phase synthesis approach to the hemi-
cyanine method for tri-, penta-, and hepta-methine cyanines using microwave assisted synthesis. As 
shown in Scheme 10, this solid-phase method first reduces reaction time by synthesizing quaternary 
ammonium salts at 150oC in acetonitrile. Next, the alkylated indolenines are reacted with resin bound 
polymethine imines 63a-c in a step accelerated by microwave irradiation. The resin allows for any sym-
metrical impurity to be cleaved before the second carboxylated indolium salt was added.43 The resin 
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bound hemicyanines 64 are then reacted with another quaternary ammonium salt synthesizing dyes 65 
which are no longer resin bound.  
O
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N R
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N
I-
N
I-
N
H
O
n
DMF, 15 min
120oC
N
O-
O
Br-
Ac2O
DIEA
pyridine
2 h
N
n
N
O-
O
n = 1, 2, 3
a = triethyl orthoformate
b = malonaldehyde bis dimethylacetal, DCM
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65  
Scheme 10. Solid-Phase Synthesis of Unsymmetrical Cyanine Dyes
43
 
 
1.4 Conclusion 
Cyanine dyes are highly modifiable compounds that have wide-ranging applications from cancer 
imaging to nucleic acid detection7-9. They are generally non-toxic44, stable and exhibit exceptional bio-
compatibility making their cellular use tremendously appealing. Due to the diverse functionality associ-
ated with them a large number have cyanines have been synthesized for various applications. 
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 2  SYNTHESIS AND OPTICAL PROPERTIES OF UNSYMMETRICAL TRIMETHINE CYANINE DYES 
2.1      Introduction 
The majority of cyanine dyes are symmetrical in that the nitrogen containing heterocycles on 
both sides of the methine chain and the alkyl groups connected to the nitrogens are the same. Until the 
mid-1900s, it was widely accepted that an unsymmetrical cyanine dye would absorb halfway between 
the absorption of the parent symmetrical dyes.27 Brooker et al. showed that if the basicities of the nitro-
gen containing heterocycles are not identical, or if the relative stabilities of the two forms are not differ-
ent, the absorption would not be at the midpoint.27 If the basicity of the two nuclei is not equal the ab-
sorption should be found at a shorter wavelength than the intermediate position. As the difference in 
basicity is continually increased, the absorption maximum gets further from the midpoint, and this devi-
ation increases with an increasing length of the polymethine chain.27 Although many monomethine un-
symmetrical cyanine dyes have been made, there is a lack in the literature of trimethine cyanine dyes 
with indolenine moieties and those with substitutions on the benzene ring of the indolenine are sporad-
ic. 
When designing new dyes for various applications, it is important to understand how altering 
the substituents on the heterocycles affects the optical properties of the dyes. These changes can be 
made to improve solubility or increase binding and permeability, but structural modifications also cause 
changes in absorption and fluorescence. Herein we report the synthesis of a series of unsymmetrical 
trimethine cyanine dyes made to determine how these substitutions affect the optical properties of the 
dyes. Molar absorptivities (ε) will be calculated using the Beer-Lambert law and fluorescence quantum 
yields (φ) will be determined by a relative method.45 Stokes shift and absorption maxima will be com-
pared to those of the symmetrical dyes. 
A common application of cyanine dyes is for imaging and labeling in vivo. Lipinski’s Rule of Five is 
used to evaluate if a chemical compound has properties that would make it orally active in humans.46 
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These properties include molecular weight, hydrogen bond donors and acceptors, a partition coffecient, 
and polar surface area.47 Partition coefficients, such as log P, are ratios of concentrations of a compound 
in a mixture of two immiscible phases. Log D is much like log P, but it also takes into account positions 
that can be fully protonated or deprotonated such as sulfonate or carboxylate groups. Based on log D, it 
can be speculated as to where a compound will distribute in biological tissues. The Lipinski Rule of Five 
properties of each dye were investigated and the log D value of each dye was predicted to give a better 
idea of how each substituent affects partitioning of the dye and where it will distribute in biological tis-
sues.  
2.2      Methods 
2.2.1 Chemicals and Instruments 
Most reagents were purchased from Sigma-Aldrich and were used without purification. Absorp-
tion spectra were recorded on a Cary 3G UV-Visible Spectrophotometer (Santa Clara, CA) in DMSO for 
dyes and 0.1 M NaOH/water solution for fluorescein standard using VWR disposable two-sided polysty-
rene cuvettes. Fluorescence (LIF) emission analyses were performed using a K2 Multifrequency Phase 
Spectrofluorometer (ISS Inc., Champaign, Il) in DMSO for dyes and 0.1 M NaOH/water solution for fluo-
rescein standard using Sigma-Aldrich disposable polystyrene fluorimeter cuvettes. Excitation was 
achieved with a 300 watt Excelitas Short Arc Xenon Lamp (Fremont, CA) at 645 nm. Slit widths were set 
to 2 mm and integration time of 3 seconds. Microsoft Excel 2010 was used for all calculations. 
2.2.2 Stock Solutions 
Stock solutions of the dyes and standard were prepared by weighing the solid on a 5-digit ana-
lytical balance in an amber vial and adding DMSO or 0.1 M NaOH solution via a class A volumetric pi-
pette. The vials were vortexed for 20 seconds and then sonicated for 5 minutes to ensure complete dis-
solution. The stock solutions were stored in a dark freezer at 4oC when not in use. 
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2.2.3 Method of Determining Molar Absorptivity and Fluorescence Quantum Yield 
Stock solutions were used to prepare six dilutions of dyes and the standard with concentrations 
ranging from 2 µM-6 µM using a class A volumetric pipette in order to maintain absorption between 0.1 
and 1.0. The dye solutions were diluted ten-fold for fluorescence in order to minimize inner filter effect. 
For the standard, fluorescence concentrations were 0.02-0.06 µM and the area under the curve was 
then multiplied by 10. The absorbance spectrum of each sample was measured in triplicate using the 
Cary 3G UV-Visible Spectrophotometer from 400-800 nm. The spectra were then normalized at 400 nm. 
The emission spectrum of each sample was measured in triplicate using the ISS K2 spectrofluorometer 
with a 465 nm excitation wavelength (λEXC). 
For molar absorptivity, the absorbance at the wavelength of maximum absorbance (λmax) was 
determined and the absorbance of each sample at λmax was plotted as a function of dye concentration 
(C). The linear regression equation was computed using Microsoft Excel software version 14. 
The fluorescence quantum yields were determined relative to the fluorescein standard utilizing 
the gradient from the plot of integrated fluorescence intensity versus absorbance (Grad), refractive in-
dex (η) and the published quantum yield of the standard (φS), as per Equation 9. In this equation, the 
subscripts S and D refer to the standards and the dyes, respectively.  
φD = φS * GradD/GradS * η
2
D/η
2
S 
Equation 9. Quantum Yield Equation 
2.2.4 Hydrophobicity Studies 
Hydrophobic characteristics of each dye were assessed by acquiring absorbance spectra in vary-
ing ratios of methanol-buffer mixture (in the range of 2-100% methanol) using phosphate buffer pH 7.4. 
The concentration of methanol was slowly increased until there was no apparent changes at which point 
the spectra overlapped. 
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2.2.5 Method of Predicting Lipinski Rule Violations 
Molecular weight was calculated without the counterion. Hydrogen bond donors and acceptors 
and log D were predicted using MarvinSketch 5.9 (ChemAxon, Budapest, Hungary). Predicted log D val-
ues were derived from the calculations by Viswanadhan,48 Klopman,49 and the PHYSPROP database at 
pH 7.4 and the three were averaged. 
2.3 Results and discussion 
2.3.1 Synthesis of Unsymmetric Trimethine Cyanine Dyes 
 
Scheme 11. Synthesis of Unsymmetrical Trimethine Cyanine Dyes 
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Equation 10. Synthesis of Benz[c,d]indole trimethine cyanine dye 79 
As shown in Scheme 1, the synthesis of quaternary indolium salts 70 began with a Fischer indole 
synthesis by reaction of 4-substituted phenylhydrazines with 3-methyl-2-butanone in boiling glacial ace-
tic acid.50-52 2-methylbenzothiazole, 2-methylbenzoxazole, and 1,1,2-trimethylbenz[e]indole 70e were 
purchased from Sigma-Aldrich. The substituted indolenines 70a-e and benzothiazoles (the dimethyl 
groups in 70 are replaced by a sulfur atom) were quaternized through SN2 reaction with alkyl halides in 
boiling acetonitrile to form salts 71 and 72. Benz[c,d]indole quaternary ammonium salts were synthe-
sized as previously described by our lab to form salts 73 and 77.53 The key step in the formation of un-
symmetrical trimethine cyanine dyes is the formation of the aldehyde 69 through a Vilsmeier reaction.54 
The aldehyde is then reacted in acetic anhydride with each quaternary ammonium salt for one hour at 
100oC to yield 13 novel unsymmetrical dyes 74-76 and 79 as shown in Scheme 11 and Equation 10. Effi-
cient synthesis yields pure dyes, but those needing purification were purified by column chromatog-
raphy using various methanol/dichloromethane ratios (1-5% methanol in dichloromethane). Dyes with 
multiple charges 74a,b,j tend to have lower yields due to the use of reverse phase column chromatog-
raphy for purification because the dyes have positive and/or negative charges that can make them to 
stick to the column. 
Compound 75c was chosen as a representative for complete chemical characterization and 
analysis. 1H NMR spectra of compound 75c measured in DMSO-d6 can be seen in Figure 5. The triplet 
that is not fully resolved at 8.04 ppm corresponds to the meso-proton Hf of the methine chain. This is 
known because the J coupling constant of this proton and the doublets at 6.81 ppm, Hg, and 6.29 ppm, 
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He, is 12.8 Hz. Hg corresponds to the proton further downfield as it is closer to the sulfur atom. The cou-
pling constant above 12 suggests that the bonds in the methine chain all show trans character. The dou-
blet at 8.09 ppm corresponds to Hk as it is the closest to the sulfur. The doublet at 7.90 ppm corresponds 
to Hh as it is close to a nitrogen atom, but also close to the sulfur. The triplets at 7.64 ppm and 7.51 ppm 
are the final two from the phenyl ring of the benzothiazole heterocycle corresponding to Hj and Hi, re-
spectively. Looking at the phenyl ring of the indolenine heterocycle, the doublet at 7.59 ppm corre-
sponds to Ha as it has the most influence from the nitrogen atom. The multiplet at 7.39 ppm corre-
sponds to Hb and Hd, and the triplet at 7.22 ppm corresponds to Hc as it is the furthest triplet from any 
polar atoms. The singlet at 3.56 corresponds to the protons on the methyl side chain, and the singlet at 
1.65 ppm corresponds to the dimethyl groups on the indolenine heterocycle. The signals at 4.44 ppm, 
1.75 ppm, and 1.45 ppm correspond to the protons of the three internal carbons on the butyl side chain 
and can be specified as closest, middle and furthest from the nitrogen, respectively, based on their split-
ting patterns. The triplet at 0.95 ppm corresponds to the protons on the terminal carbon of the butyl 
side chain. 
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Figure 5. 
1
H NMR spectrum of 75c in DMSO-d6 at 25°C 
13C NMR spectrum of 75c measured in DMSO-d6 shows all 6 aliphatic carbons below 50 ppm as 
seen in Figure 6. Of the 18 other expected peaks, 16 are seen. The remaining two would are most likely 
ipso carbons and would need more scans to show up. Liquid chromatography coupled with a UV detec-
tor as depicted in Figure 7 shows one peak meaning the compound is very pure. High resolution mass 
spectrometry (Figure 8) shows a peak at 399.2061 which is within the acceptable range from the calcu-
lated value of 389.2046, confirming the compound. All final dyes were characterized using the same 
techniques as described for 75c. 
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Figure 6. 
13
C NMR spectrum of 75c in DMSO-d6 at 25°C 
 
 
Figure 7. Liquid Chromatography of 75c 
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Figure 8. High Resolution Mass Spectrograph of 75c 
2.3.2 Optical properties 
Dye 74d was dissolved in numerous solvents that all of the dyes were soluble at a constant 
concentration of 3 μM. The effect of differing the solvent on absorption was investigated using 
acetonitrile, DMSO, ethanol and methanol and can be seen in Figure 9. The dyes had the highest 
absorption in ethanol and absorbed at the longest wavelength in DMSO. Methanol and acetonitrile 
showed no difference from each other. The dyes were best soluble in DMSO and therefore DMSO was 
chosen as the solvent for the studies as shown in Figure 9. 
 
Figure 9. Solvent effects on the absorption of 74d A) full spectrum B) zoomed in to λmax 
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Figure 10 shows an example of the absorption of dye 74a at various concentrations tested. 
These absorption values were used to determine the molar absorptivity using Beer’s Law. The 
absorption shifts caused by the different heterocycles can be seen in Figure 11. The absorption λmax of 
trimethine cyanine dyes containing two indolenine bases is usually 552-553 nm in DMSO, and the 
fluorescence λmax is usually 565 nm. The most notable shifts come from dyes whose heterocycles have 
some 
 
Figure 10. Absorption Spectrograph of 74a Figure 11. Absorption spectra of various dyes at 3 μM 
interaction with the conjugation. For instance, the oxygen in benzoxazole heterocycles has more 
interaction with the conjugated methine chain than the sulfur in benziothiazole heterocycles does. As 
shown in Table 1, the observed chemical shift of the meso-proton in proton NMR is most likely due to 
electronegativity from the surrounding atoms. Oxygen is more electronegative than sulfur and therefore 
pulls more electrons from the methine chain shifting the meso-proton to 8.34 ppm. Sulfur is only slightly 
Table 1. Meso-proton shifts in relation to absorption wavelength 
Dye Meso-proton shift  (ppm) λmax(nm) 
76a 8.91 672 
74d 8.55 552 
75a 8.40 549 
75b 8.34 516 
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more electronegative than carbon and shows a meso-proton shift of 8.40 ppm corresponding to an ab-
sorption λmax of 549 nm. corresponding to the smaller meso-proton shift and shift in λmax. The 
benz[c,d]indole heterocycle shows the largest shift in both the meso-proton and λmax, 8.91 ppm and 672 
nm, respectively. This is due to the increased conjugation in the heterocycle pulling more electrons from 
the methine chain.  Figure 12 shows the electrostatic maps of these dyes next to their proton NMR to 
give a visual representation of how the heterocycles interact differently with the methine chain. 
  
Figure 12. Shift of meso-proton due to changing heterocycles 
Optical properties for the dyes can be seen in Table 2. The dyes containing bromine substituted 
indolenine 74j and 74f, benz[e]indole 74i, and benzoxazole 75b show λmax directly between where 
symmetrical dyes of the two heterocycles would absorb. This is because the heterocycles are equivalent 
in basicity to one another, but the bromine in dye 74f did cause an increase in molar absorptivity. The 
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λmax of the dye containing an electron donating methoxy substitution on the indolenine 74g and 
benz[c,d]indole 76a was not in the expected position directly in between the λmax of the two symmetric 
dyes the center showing that the methoxy group affects the basicity of the heterocycle more than the 
bromine does. This dye 74g also showed lower molar absorptivity and the lowest quantum yield due to 
the electron donating nature of the methoxy group introducing electron density back into the system. 
Dyes 74a-c all have two unsubstituted indolenine heterocycles and show molar absorptivity in the range 
of 120,000-127,000 M-1cm-1. This shows that the heterocycle has more effect on molar absorptivity than 
the side chain. The inclusion of a sulfonate group on the heterocycle increases the molar absorptivity. 
The molar absorptivity of dyes containing benzothiazole and benzoxazole heterocycles is also slightly 
lower than those with two indolenine heterocycles. The addition of a benz[c,d]indole heterocycle causes 
a shift over 100 nm and makes the dye blue in color, but also causes a decrease in molar absorptivity. 
Adding two benz[c,d]indole heterocycles shifts absorption to the near-infrared region showing a λmax of 
758 nm. These shifts are of importance to imaging because it allows the fluorescence of trimethine 
cyanine dyes to be closer to the  
Table 2. Summary of Optical Properties 
Dye λmax
 
Emax
 
Stokes 
shift 
%QY 
(+/- .02%) 
ε (M
-1
cm
-1
) 
(+/- 2%) 
74a 552 565 13 8.25 120765 
74b 553 565 12 10.20 124614 
74c 552 565 13 7.45 127270 
74d 552 565 13 10.44 137626 
74e 553 567 14 8.57 115683 
74f 556 569 13 12.55 128682 
74g 566 585 19 3.81 94067 
74h 556 570 14 10.68 144811 
74i 572 586 14 10.01 107011 
74j 556 568 12 11.68 101544 
75a 549 569 20 7.21 112322 
75b 516 537 21 10.27 111054 
76a 672 - - - 75211 
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NIR range where there is less autofluorescence from biological tissue, but comes at the price of lower 
quantum efficiency. Lee et al. have shown that the benz[c,d]indole moiety causes a large decrease in 
fluorescence lifetime.54 This is probably due to the planar nature of these heterocycles allowing for 
easier stacking. The dye containing a benzoxazole heterocycle 75b had a blue shift further from the NIR 
region, it also had an increased stokes shift of over 20 nm. As mentioned before this is likely due to the 
electronegativity of the oxygen atom. 
The majority of the dyes have a quantum yield around 10%. Dye 74f with the bromine 
substituent on the heterocycle was slightly higher at 12.5%. This may be due to its higher molar 
absorptivity. The benzoxazole containing dye 74b was also close to 10%, but the benzothiazole dye was 
lower around 7%. Benzoxazole dyes tend to have higher quantum yield due to the lone pair of the 
oxygen stabilizing the excited state, while the sulfur atom in benzothiazole dyes causes the opposite 
effect. 
Another interesting property of the dyes is their apparent aggregation as seen in Figure 13. 
Cyanine dyes are known to aggregate, but in our study of unsymmetric trimethine cyanines, as the 
concentration of each sample was increased the ratio of the two peaks remained constant suggesting 
that the spectral representation of these compounds does not show aggregation in DMSO. In addition 
the second absorption maxima at the lower wavelength are not present in the dyes with a benzothiazole 
or benzoxazole moiety. The second peak has been attributed to the more pronounced H-band 
associated with dyes containing two dimethyl-indolenine heterocycles. 
2.3.3 Hydrophobicity 
Cyanine dyes are typically very soluble in DMSO, therefore hydrophobicity studies were carried 
out in methanol-buffer mixtures. As the polarity of the solvent decreased with increasing methanol 
concentration from 2% to 100% a general amplification of the monomeric band was observed. As the 
polarity decreases there is also an increase of the ratio of monomer band to the aggregate band up to 
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30% methanol when the ratio becomes steady. The increased absorbance is related to the defragmenta-
defragmentation of aggregate to form monomers. As reported by Beckford et al. this aggregation is 
predominantly due to a plane-to-plane arrangement.55 Although this aggregation is still seen in 
unsymmetrical dyes at higher polarities the aggregation is not as obvious compared to symmetrical 
dyes. This is likely due to the two different heterocycles not stacking as easily as heterocycles that are 
the same, i.e. two benzothiazole heterocycles stacking together better than a benzothiazole and an 
indolenine heterocycle stack. In addition, these dyes all include one methyl side chain, so the effect of 
increasing the length and subsequent hydrophobicity of only one side would be expected to have a 
smaller effect on aggregation. Examples of this can be seen in Figure 13. Increasing the hydrophobicity 
of the dye by changing indolenine to benze[e]indolenine to benz[c,d]indolenine increases the amount of 
aggregation seen in higher polarity solvent. 
 
Figure 13. Absorption spectra of cyanine dyes as a function of increasing solvent hydrophobicity (% 
v/v methanol to buffer) at constant dye concentration at constant dye concentration of 10 μM (A) 74d 
(B)74i (C) 76a 
 
To show that the vast majority of hydrophobic effects are due to the heterocycle, an 
unsymmetrical dye 79 containing two benz[c,d]indole heterocycles with one methyl and one butyl side 
chain was synthesized as shown in Equation 11. The hydrophobic effects of this dye were compared to 
the dye reported by Beckford et al.55 and as shown in Figure 14 there is almost no hydrophobic change 
observed from changing one butyl group to a methyl group. 
31 
 
Figure 14. Absorption spectra of 79 compared to a symmetrical dye synthesized by Beckford et al.
55
 as 
a function of solvent hydrophobicity (% v/v methanol to buffer) at constant dye concentration of 10 
μM 
 
Changes in the hydrophobic nature of these dyes can make them less biocompatible with regard 
to uptake and biodistribution in vivo. Table 2 shows that altering the heterocycle from indolenine to 
benze[e]indolenine to benz[c,d]indolenine causes a red shift in absorption but also a decrease in 
quantum efficiency. A possible way to counter this decrease in quantum efficiency is through the use of 
unsymmetrical dyes. By changing only one heterocycle biocompatibility may be retained while only 
losing a small portion of the dye’s quantum efficiency. The improved solubility of these less hydrophobic 
dyes also increases their attractiveness as biological probes. These increases in hydrophobicity can be 
predicted through log D values as shown in Table 3. 
2.3.2 LogD 
The Lipinski Rule properties for each dye can be seen in Table 3. The molecular weight was 
calculated without the counterion as it would be lost in in vivo applications. The only dyes that didn’t 
meet the Lipinski Rule for molecular weight were 74h and 74j due to the addition of heavy substituents, 
such as bromine, to the heterocycle already containing the trimethylammonium side chain. None of the 
dyes contain any hydrogen bond donors. All of the dyes meet both rules for hydrogen bond donors and 
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acceptors. They also all meet polar surface area requirements. Three dyes 74e,f,i, had log D above the 
Lipinski Rule value, therefore 8 of the 13 dyes synthesized meet all the Lipinski rules. One common use 
of trimethine dyes is for cell staining. According to Burton et al.56 an incremental increase in cell 
permeability is seen with an increase in partition coefficient, so it would be expected that the dyes with 
the  
Table 3. Summary of Lipinski Rule Properties 
Dye Molecular 
Weight 
H 
bond 
donors 
H bond 
acceptors 
Polar 
Surface 
Area (Å2) 
Log D Meets 
Criteria 
74a 443.66 0 1 6.25 -2.15  
74b 464.61 0 4 71.85 3.03  
74c 371.53 0 1 6.25 3.38  
74d 399.59 0 1 6.25 4.35  
74e 461.65 0 1 6.25 5.49  
74f 478.48 0 1 6.25 5.12  
74g 429.61 0 2 15.48 4.19  
74h 522.72 0 4 71.83 -0.94  
74i 449.64 0 1 6.25 5.34  
74j 522.56 0 1 6.25 -0.28  
75a 347.49 0 1 31.55 1.19  
75b 373.51 0 2 15.48 1.72  
76a 407.56 0 1 6.25 4.16  
 
highest log D shown in Table 3 would have the best cell permeability. The dyes with a butyl subtituents 
74d,f,g,i and propylphenyl 74e substituents on them have high log D values, especially the butyl 
substituent on the benz[e]indole moiety. The dyes with the lowest log D values are those with more 
than one charge 74a,b,h,j and the benzoxazole moiety 75b. It would be expected that these dyes would 
have a lower probability of crossing the cell membrane, but may be more suitable for other applications. 
2.4 Conclusions 
A series of 13 novel unsymmetrical trimethine cyanine dyes was synthesized in very good yield, 
purified, and characterized by 1H NMR, 13C NMR, liquid chromatography, and mass spectrometry. Their 
optical properties including absorption, fluorescence, stokes shift, molar absorptivity, and quantum yield 
33 
were studied. Solvent effects were evaluated and DMSO was determined to be the best solvent for 
studying the optical properties. Dyes with electron withdrawing substitutions on the heterocycle show 
increased molar absorptivity while those with electron donating groups show lower molar absorptivity. 
These changes in molar absorptivity are likely also the cause for parallel changes in quantum yield. 
Unsymmetrical dyes can be used to fine tune absorption wavelengths without the loss of other 
favorable properties such as quantum yield. Unsymmetrical dyes were shown to not aggregate as much 
as symmetric dyes most likely due to the inability of the different heterocycles to stack as well. 
Trimethine cyanine dyes could make good oral drugs as the majority of them meet Lipinski’s Rule of 
Five. 
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3 SYNTHESIS AND EVALUATION OF TRIMETHINE CYANINE DYES AS PROTEIN ARGININE METHYL 
TRANSFERASE INHIBITORS AND IMAGING AGENTS 
3.1 Introduction to Protein Arginine Methyltransferase 
Arginine differs from other amino acids in that its side chain contains more potential hydrogen 
bond donors than other amino acids.57 A common post-translational modification (PTM) of arginine is 
methylation. This is achieved by a family of enzymes called protein arginine methyltransferases (PRMTs). 
A three-dimensional model of rat PRMT1 can be seen in Figure 15.58 This family of nine enzymes found  
 
Figure 15. 3D Structure of Rat PRMT1 with Substrate and co-factor Bound
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in mammalian genomes has important roles in signal transduction, gene transcription, DNA repair, 
mRNA splicing, and many other biological activities that affect cell growth, proliferation and 
differentiation.59 PRMTs catalyze three types of arginine methylation as shown in Figure 16. The first is 
monomethylation which is done by all PRMTs. Type III PRMTs only monomethylate. Monomethylation is 
a precursor of dimethylation which can be asymmetric (Type I) or symmetric (Type II). PRMT1 and 
PRMT5 are the major asymmetric and symmetric arginine methyltransferases, respectively. The other 
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PRMTs have fewer substrates and more specialized roles. Although alterations are generally not found 
in PRMTs, various cancers including breast cancer, prostate cancer, and leukemia have been linked to 
overexpression of these enzymes making them viable targets for therapeutic strategies.59 
 
Figure 16. Types of Methylation on Arginine Residues 
The prominent asymmetric arginine methyltransferase, PRMT1, accounts for over 90% of 
methylarginine residues in mammalian cells.60 Its activity at arginine 3 on histone H4 has been positively 
correlated with increasing tumor grade and can be used to predict the risk of reoccurrence of prostate 
cancer.61 PRMT1 has also been associated with telomeric repeat-binding factor 2, a component that 
protects telomeres.62 It is widely accepted that the deregulation of telomeric maintenance and the DNA 
repair pathway has a major role in carcinogenesis. Inhibition of this pathway may stimulate the 
accumulation of DNA damage. Overexpression of another target of PRMT1, the oestrogen receptor, has 
been implicated in the pathogenesis of breast cancer.63 Two studies in mice have also shown that 
PRMT1 may be responsible for leukemia development.64,65 These studies suggest that inhibitors specific 
for PRMT1 may have a therapeutic effect on leukemia as well as anti-cancer activity. 
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The key type II arginine transferase, PRMT5,66 shows oncogene-like properties in its ability to re-
pression the expression of tumor suppressor genes. Higher levels of PRMT5 have been seen in trans-
formed cells and mice with no PRMT5 show a slowed cell growth, while those overexpressing PRMT5 
show cellular hyperproliferation.67 Epithelial-mesenchymal transition, a normal process by which cells 
become less adhesive more mobile causes cancerous cells to become metastatic.59 PRMT5 plays an im-
portant role in epithelial-mesenchymal transition. 
Although PRMT has only recently been linked to cancer59, early studies have been quite 
circumstantial. The field of small-molecule PRMT inhibitors is still in its early stages, but the knowledge 
gained from these initial studies allows for the prompt evaluation of tricarbocyanines in vivo efficacy as 
PRMT inhibitors.59  
 
Figure 17. Current PRMT Inhibitors
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The first non-nucleoside specific inhibitors of PRMTs were discovered in 2004 through random 
screening, some of which are shown in Figure 17.69 Stilbamidine and AMI-1 have IC50 values of 57 μM 
and 8.8 μM, respectively68. It remains difficult to develop selective and potent PRMT inhibitors due to 
PRMTs highly conserved binding pockets.70 An important characteristic of carbocyanines is their 
absorption and fluorescence in the near-IR range which offers a great advantage for in vivo fluorescent 
imaging with minimal background fluorescence from biomolecular autofluorescence. Relative changes in 
the absorption or emission spectra of cyanine dyes caused by binding of biomolecules can be studied 
spectrophtometrically.14 Previously, our lab has synthesized a series of trimethine dyes using the 
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indolenine, benz[e]indole, and benz[c,d]indole heterocycles to test for PRMT1 binding.53 Through this 
series it has  
 
Figure 18. Probable binding regions of trimethine cyanine dyes on PRMT 
been shown that trimethine cyanine dyes inhibit PRMT1 in a noncompetitive, reversible fashion, bind 3 
regions on PRMT (Figure 18), accumulate in the nucleus of HeLa cells (Figure 19), and can be seen under 
visible microscope (Figure 19A) or by fluorescence (Figure 19B).53 These dyes can be a powerful tool in 
revealing mechanisms and functions of PRMTs.  
 
Figure 19. Accumulation of Trimethine Cyanine Dye in the Nucleus of Hela Cells Under (A) Visible  
Microscope and (B) Fluorescence 
There has only been one study done using carbocyanines as PRMT inhibitors.53 This study which 
yielded good results tested symmetrical dyes containing indolenine, benz[e]indole, and benz[c,d]indole 
heterocycles. In order to further decrease IC50values, this study began by creating unsymmetrical dyes 
with one indolenine heterocycle and one benzothiazole heterocycle in hopes that removal of one of the 
A B 
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dimethyl groups may allow for better binding. From this initial study, it was determined that the benzo-
benzothiazole heterocycle could be important to PRMT inhibition and therefore benzothiazole 
containing symmetrical dyes similar to the dyes previously published were synthesized. Each 
modification will be discussed in detail throughout the rest of this chapter and the anti-PRMT activity 
will be compared with data from our previous study.53 
3.2 Unsymmetric Trimethine Cyanine Dyes for PRMT Inhibition 
 
Scheme 12. Synthesis of Unsymmetric Dyes for PRMT Inhibition Screening 
This research concentrates on the development of unsymmetrical benzothiazole-containing 
hydrophobic trimethine cyanine dye derivatives utilizing ethyl, butyl and phenylpropyl halides for 
nitrogen alkylation. Initial synthesis for this work involved the development of a series of unsymmetric 
trimethine cyanine dyes as described in Scheme 11 and Scheme 12. Quaternization of commercially 
obtained benzothiazole and synthesized indolenine containing compounds proceeds through an SN2 
reaction with alkyl halides using either acetonitrile or no solvent. These quaternary ammonium salts are 
then reacted with aldehyde in acetic anhydride at 100°C for 1 hr. The workup for these dyes involves 
precipitation in diethyl ether and decanting the solvent, before washing with ether and filtering. 
Efficient synthesis gives good yield and high purity compounds, but those needing additional purification 
were purified by column chromatography (4% methanol in dichloromethane). 
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Synthesized trimethine cyanine dyes were screened for anti-PRMT1 and PRMT5 activity to com-
pare against the indolenine based series.53 Typical anti-PRMT screening assays include recombinantly 
expressed His-tagged PRMT [14C]-labeled AdoMet, and a histone H4 peptide containing the 20-amino 
acid sequence on the N-terminal tail of histone H4. A 30 mL sample is heated at 30°C and the degree of 
diminishment of PRMT activity is used to evaluate the potency of the compounds. Dyes showing promis-
ing activity from the screening were supplemented to IC50 studies. 
Initial screening assays were done on the unsymmetrical cyanine dyes. Results from the anti-
PRMT activity and IC50 studies are shown in Table 4. These data show that unsymmetrical dyes 
containing benzothiazole moieties, specifically 82a and 82c, inhibited PRMTs well, while dyes with 
benzoxazole moieties 75b (Scheme 11) show less inhibition. The dyes with additional charges 74a,b,h 
(Scheme 11) did not show any PRMT inhibition concluding that additional cations on the cyanine core 
decrease the efficacy of PRMT inhibition. 
After screening, the three dimensional structure and log D values of these dyes at pH 7.4, shown 
in Figure 19, were predicted to better draw a correlation between structure and activity. All of the dyes 
have molecular weight less than 500 and polar surface area less than 140 Å. All dyes with potent 
inhibition had log D values above 4 and the dyes with extra charges had log D values of 3 and below. In 
addition, the oxygen atom in the benzoxazole containing dye led to a log D below 2. Compound 82a was 
the  
Table 4. Anti-PRMT activity of unsymmetrical dyes 
Compound Remaining 
PRMT1 activity 
Remaining 
PRMT5 activity 
PRMT1 
IC50 (µM) 
PRMT5 
IC50 (µM) 
Ratio of IC50 
PRMT1/IC50 PRMT5 
74a 1.23 0.710 nd nd nd 
74b 1.08 0.640 nd nd nd 
74c 1.13 0.510 nd nd nd 
74d 1.17 0.400 >20 13.9 >1.43 
74e 0.452 0.302 nd nd nd 
74f 0.155 0.340 nd nd nd 
74h 1.08 0.800 nd nd nd 
75b 0.573 0.680 nd nd nd 
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82a 0.012 -0.049 6.11 5.42 1.13 
82b 0.629 0.277 37.5 10.7 3.5 
82c 0.484 0.236 9.46 11.92 0.79 
*nd = not determined  
first unsymmetrical benzothiazole containing dye tested and showed excellent inhibition with IC50 values 
of 6.11 μM and 5.42 μM for PRMT1 and PRMT5, respectively. This dye led to the designing of a second 
series of symmetrical dyes containing the benzothiazole heterocycle with higher log D values. The next 
synthetic step based on these predictions and the screening results was to design benzothiazole 
containing symmetrical trimethine cyanines based on our previous set of compounds.53 
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Figure 20. Three Dimensional Structures and Log D values of Unsymmetric Trimethine Cyanines 
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3.3 Symmetric Trimethine Cyanine Dyes for PRMT Inhibition 
 
Scheme 13. Synthesis of Unsubstitued Symmetrical Trimethine Cyanine Dyes for PRMT Inhibition 
Screening 
 
The synthesis of symmetrical benzothiazole containing trimethine cyanine dyes begins with the 
alkylation of 2-methylbenzothiazole 83 with alkyl halides by refluxing without solvent. The 
corresponding salts are then washed with ether to remove impurities. Individual salts 84a-c are then 
reacted with triethyl orthoformate in acetic anhydride for two hours. The reaction is allowed to cool to 
room temperature and the solution is poured into ether. The ether is decanted and the solid is washed 
with ether several times before filtering the dyes. No column chromatograph purification was needed 
and these dyes were synthesized in yields ranging from 66%-72%. All dyes were fully characterized as 
discussed in Chapter 1. Screening assays, using the same procedure as described before, revealed that 
dye 85a showed the best PRMT1 inhibition for this series corresponding to a 27.21 µM IC50 value as 
shown in Table 5. Dye 85c showed the lowest remaining activity for PRMT5 which is expected to be an 
IC50 value below 10 based on a comparison of the screening activity of 85a and 85c for PRMT5. This 
shows that increasing the length and/or size of the N-alkyl side chain has a better effect on PRMT5 than 
PRMT1. Due to our previous results53 indicating that compounds with higher log D values show better 
inhibition, the next step was to synthesize symmetrical dyes with increased hydrophobicity by adding a 
bromine atom. 
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Table 5. Anti-PRMT Activity of Benzothiazole-containing Symmetrical Dyes  
Compound Remaining 
PRMT1 activity 
Remaining 
PRMT5 activity 
PRMT1 
IC50 (µM) 
PRMT5 
IC50 (µM) 
Ratio of IC50 
PRMT1/IC50 PRMT5 
85a 0.144 0.353 27.21 12.65 2.15 
85b 0.173 0.331 nd nd nd 
85c 0.186 0.323 nd nd nd 
*nd = not determined 
 
 
Figure 21. Three Dimensional Structures and Log D values of Symmetric Trimethine Cyanines 
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Scheme 14. Synthesis of Bromine Substituted Benzothiazole Containing Trimethine Cyanine Dyes 
Dye 85b with an N-butyl side chain was chosen for further modificiation due to its moderate 
activity for both PRMT1 and PRMT5. Bromine was added to increase log D from 3.92 to 5.46. To observe 
whether there was a spacial factor, bromine atoms were added in two different positions. Symmetrical 
trimethine cyanine dyes were synthesized by the same method described in Scheme 13, only starting 
with 5-bromo-2-methylbenzothiazole 86a and 6-bromo-2-methylbenzothiazole 86b. Because these 
compounds are solids and not liquid like unsubstitued 2-methylbenzothiazole, the alkylation of 86a-b 
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was carried out in boiling acetonitrile. The pure dyes were synthesized in very good yield over 75%. As 
shown in Table 6, the bromine substitution decreased anti-PRMT activity, possibly due to electrostatic 
interactions caused by the electronegativity of the bromine atom, shown in Figure 22. Previous results53 
indicated that dyes containing benz[e]indole heterocycles acted as potent PRMT inhibitors. 
Table 6. PRMT Inhibition of Bromine Substituted Benzothiazole Containing Trimethine Cyanine Dyes  
Compound Remaining 
PRMT1 activity 
Remaining 
PRMT5 activity 
PRMT1 
IC50 (µM) 
PRMT5 
IC50 (µM) 
Ratio of IC50 
PRMT1/IC50 PRMT5 
88a 0.488 0.662 nd nd nd 
88b 0.544 0.656 nd nd nd 
*nd = not determined 
 
Figure 22. Three Dimensional Structures and Log D values of Bromine Substituted Symmetric 
Trimethine Cyanines 
 
 
Scheme 15. Synthesis of Napthothiazole Containing Symmetrical Trimethine Cyanine Dyes 
Napthothiazole structurally mimics the benz[e]indole heterocycle that was used in our previous 
study.53 To further modify this structure the same systematic set of N-alkyl side chains were 
incorporated as the initial series of symmetric dyes discussed earlier. As described in Scheme 15 alkyl 
45 
halides were refluxed in acetonitrile with 2-methylnaptho[2,1-d]thiazole 89 to form quaternary 
ammonium salts 90a-c. Dyes 91a-c were formed in 50-70% yield following the same procedure as 
described in Schemes 13 and 14. Dye 91c with the phenylpropyl substituent had a lower yield due to the 
precursor quaternary ammonium salt 90c not being completely pure. As shown in Table 7, dye 91a-c 
containing napthothiazole substituents with ethyl side chains significantly diminished PRMT1 suggesting 
that this heterocycle is advantageous. The instrument for IC50 determinations was not sensitive enough 
to determine the actual IC50 for this dye, but it is expected to be between 1 and 2 µM. Dye 91b also had  
Table 7. PRMT Inhibition of Napthothiazole Containing Trimethine Cyanine Dyes  
Compound Remaining 
PRMT1 activity 
Remaining 
PRMT5 activity 
PRMT1 
IC50 (µM) 
PRMT5 
IC50 (µM) 
Ratio of IC50 
PRMT1/IC50 PRMT5 
91a 0.023 0.166 <5 <5 nd 
91b 0.071 0.191 <5 <10 nd 
91c nd nd 5.21 >10 >2 
*nd = not determined 
excellent anti-PRMT1 activity from the screening assay and has better selectivity toward PRMT1 than 
dye 91a. Three dimensional structures and log D values for these compounds can be seen in Figure 23. 
In this series we see a decrease in PRMT5 potency with increasing side chain length, the opposite of 
what was seen with benzothiazole heterocycles. This probably has to do with the size of the compound 
getting too large to fit in the binding region. 
 
Figure 23. Three Dimensional Structures and Log D values of Napthothiazole Containing Symmetric 
Trimethine Cyanines 
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3.4 Conclusion 
 PRMTs have been linked to a variety of cancers, therefore the designing of potent small 
molecule inhibitors is highly desired. Trimethine cyanine dyes containing substituted and unsubstituted 
benzothiazole heterocycles and hydrophobic substituents were synthesized and several possessed single 
digit micromolar potency for PRMT1 and PRMT5 inhibition. Cyanine dyes tend to have long-wavelength 
absorption and fluorescence properties allowing them to be used as probes in vivo. The compound 
containing napthothiazole heterocycles with ethyl substituents had the highest potency for PRMT1 and 
PRMT5. Bromination of the benzothiazole heterocycle decreased potency. Compounds with multiple 
charges show no anti-PRMT activity. Through the synthesis and analysis of these compounds new routes 
should be explored including the synthesis of unsymmetric compounds with a napthothiazole 
heterocycle and the addition of meso substitutions. Overall, this study provides unique photoactive 
chemical molecules for both PRMT inhibition and imaging.  
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4     CONCLUSIONS 
The synthesis of 25 symmetrical and unsymmetrical trimethine cyanine dyes and their 
characterization was reported and will be indicated in the experimental section. It has been shown that 
the addition of electron withdrawing substituents to the heterocycle can increase molar absorptivity and 
quantum efficiency of cyanine dyes. Unsymmetrical dyes can be used to fine tune absorption 
wavelengths without the loss of other favorable properties such as quantum yield and may be used to 
counteract the aggregation of cyanine dyes. Hydrophobic cyanine dyes containing ethyl substituents 
have shown the highest potency for PRMT1 and PRMT5. Dyes with multiple charges show no anti-PRMT 
activity. Through the work presented in this thesis it has been shown that cyanine dyes are a 
comprehensive class of compounds that can be modified to interact in a selective fashion for a 
multitude of applications spanning the breadth of chemistry and biology even outside of their niched 
use as probes for fluorescent labeling.   
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5 EXPERIMENTAL 
5.1 Chemicals and Instruments 
Most reagents were purchased from Sigma-Aldrich and were used without purification. 1H NMR and 13C 
NMR spectra were recorded on a Bruker Avance (400 MHz) spectrometer. High resolution mass spectra 
(HRMS) were obtained using a Waters Q-TOF micro (ESIQ-TOF) mass spectrometer. 
 
2-(1,3,3-trimethylindolin-2-ylidene)acetaldehyde, 69: Phosphorous oxychloride was added dropwise to 
cold N,N-dimethylformamide, not allowing the temperature to go above 5oC to form a Vilsmeier-Haack 
reagent. The Vilsmeier-Haack reagent was added dropwise to 1,2,3,3-tetramethyl-1H-indolium iodide 
and the reaction was refluxed for one hour. The solution was then cooled to room temperature, poured 
into a cold solution of sodium perchlorate in methanol and left in the freezer to crystallize overnight. 
The solid was collected by vacuum filtration and dissolved in chloroform. The chloroform solution was 
then heated with a 20% sodium hydroxide/water solution for 24 hours. The organic phase was then 
washed with water three times and dried with sodium sulfate. The solvent was then removed by rotary 
evaporation to leave a reddish-orange solid 2; mp 104-106oC, 26% yield (lit mp 116oC, 60% yield71).  
5.1 Indoles 
5-methoxy-2,3,3-trimethyl-3H-indole, 70b: A mixture of 4-methoxyphenylhydrazine hydrochloride and 
3-methyl-2-butanone was refluxed in glacial acetic acid for 24 hrs. Acetic acid was then removed by 
rotary evaporation and the solution was diluted with dichloromethane. Sodium bicarbonate was added 
to neutralize any remaining acid and the 5-methoxy-2,3,3-trimethyl-3H-indole 70b was extracted three 
times with 50 mL dichloromethane, dried with magnesium sulfate, and concentrated under vacuum to 
form a brown oil; 91% yield (lit 95% yield72). 
sodium 2,3,3-trimethyl-3H-indole-5-sulfonate, 70c: was synthesized by our group as previously 
reported.5 
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5-bromo-2,3,3-trimethyl-3H-indole, 70d: was synthesized by a similar procedure to 70b; 91% yield (lit 
98% yield72). 
5.2 Quaternary Ammonium Salts 
2,3,3-trimethyl-1-(3-(trimethylammonio)propyl)-3H-indol-1-ium bromide, 71a: was synthesized by our 
group as previously reported.5 
3-(2,3,3-trimethyl-3H-indol-1-ium-1-yl)propane-1-sulfonate, 71b: A mixture of 2,3,3-trimethyl-3H-
indole and 1,3-propane sultone were refluxed in toluene for 18 hrs. The reaction was cooled to room 
temperature and the product was filtered and washed with ether and acetone; mp 118-120oC, 41% yield 
(lit mp 126-128oC, 87% yield73). 
1-ethyl-2,3,3-trimethyl-3H-indol-1-ium iodide, 71c: A mixture of 2,3,3-trimethyl-3H-indole and 
iodobutane were refluxed in toluene for 72 hrs. The reaction was cooled to room temperature and the 
solution was poured into cold ether and the precipitate was filtered; mp 217-221oC, 82% yield (lit mp 
165-166oC53). 
1-butyl-2,3,3-trimethyl-3H-indol-1-ium iodide, 71d: was synthesized by a similar procedure to 71c; mp 
116-119oC, 80% yield (lit mp 102oC, 83% yield53). 
2,3,3-trimethyl-1-(3-phenylpropyl)-3H-indol-1-ium bromide, 71e:  was synthesized by a similar 
procedure to 71c; mp 156-158oC, 86% yield; 1H NMR (400 MHz, DMSO- d6): δ 7.98 (t, J = 5.2 Hz, 1 H), 
7.84 (t, J = 5.2 Hz, 1 H), 7.46 (m, 2 H), 7.29 (m, 5 H), 4.51 (t, J = 8.0 Hz, 2 H), 2.81 (m, 5 H), 2.17 (m, 2 H), 
1.53 (s, 6 H); 13C NMR (100 MHz, DMSO-d6): δ 14.3, 22.0, 28.8, 31.7, 47.4, 54.1, 115.4, 123.5, 126.0, 
128.2, 128.3, 128.8, 129.3, 140.6, 141.0, 141.8, 196.6; HRMS: Calcd for C20H24N
+ m/z 278.1904, obsd m/z 
278.1915. 
5-bromo-1-butyl-2,3,3-trimethyl-3H-indol-1-ium iodide, 71f: was synthesized by a similar procedure to 
71c; mp 176-178oC, 78% yield; 1H NMR (400 MHz, DMSO- d6): δ 0.93 (t, J = 7.2 Hz, 3 H), 1.43 (m, 2 H), 
1.55 (s, 6 H), 1.80 (m, 2 H), 2.85 (s, 3 H), 4.45 (t, J = 7.2 H, 2 H), 4.43 (t, J = 7.6 Hz, 2 H), 7.83 (d, J = 8.4 Hz, 
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1 H), 7.97 (d, J = 8.4 Hz, 1 H), 8.19 (s, 1 H); 13C NMR (100 MHz, DMSO-d6): δ 14.08, 14.83, 19.79, 22.31, 
29.68, 48.23, 54.92, 117.99, 123.28, 127.39, 132.32, 140,89, 144.65, 197.43; HRMS: Calcd for C15H21NBr
+ 
m/z 294.0852, obsd m/z 294.0853. 
1-butyl-5-methoxy-2,3,3-trimethyl-3H-indol-1-ium iodide, 71g: was synthesized by a similar procedure 
to 71c; mp 145-147oC, 56% yield; 1H NMR (400 MHz, DMSO- d6): δ 0.93 (t, J = 7.2 Hz, 3 H), 1.43 (m, 2 H), 
1.53 (s, 6 H), 1.80 (m, 2 H), 2.80 (s, 3 H), 3.86 (s, 3 H), 4.43 (t, J = 7.6 Hz, 2 H), 7.13 (dd, J = 10.8 Hz, 1 H), 
7.50 (s, 1 H), 7.89 (d, J = 9.2 Hz, 1 H); 13C NMR (100 MHz, MeOD-d6): δ 12.44, 19.14, 21.61, 29.09, 47.93, 
53.81, 55.78, 108.43, 114.50, 116.04, 133.49, 143.54, 160.71, 192.31; HRMS: Calcd for C16H24NO
+ m/z 
246.1852, obsd m/z 246.1857. 
2,3,3-trimethyl-1-(3-(trimethylammonio)propyl)-3H-indol-1-ium-5-sulfonate bromide, 71h: was 
synthesized by our group as previously reported.5 
3-butyl-1,1,2-trimethyl-1H-benzo[e]indol-3-ium iodide, 71i: was synthesized by a similar procedure to 
71c; mp 142-145oC, 87% yield (lit mp 127-129oC, 90% yield22). 
5-bromo-2,3,3-trimethyl-1-(3-(trimethylammonio)propyl)-3H-indol-1-ium bromide, 71j: was 
synthesized by our group as previously reported.74 
2,3-dimethylbenzo[d]thiazol-3-ium iodide, 72a: was synthesized by a similar procedure to 71c; mp 217-
219oC, 84% yield (lit mp 218-220oC, 88% yield75). 
3-butyl-2-methylbenzo[d]thiazol-3-ium iodide, 72c:  was synthesized by a similar procedure to 71c; mp 
115-116oC, 94% yield (lit mp 114-115oC, 67% yield76). 
1-butyl-2-methylbenzo[c,d]indol-1-ium iodide, 73a: was synthesized by our group as previously 
reported.53 
3-butyl-2-methylbenzo[d]thiazol-3-ium iodide, 81b:  was synthesized by a similar procedure to 71c; mp 
115-116oC, 94% yield (lit mp 114-115oC, 67% yield76). 
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6-bromo-3-butyl-2-methylbenzo[d]thiazol-3-ium iodide, 81c: was synthesized by a similar procedure to 
71c; 60% yield; 1H NMR (400 MHz, DMSO-d6): δ 0.93 (t, J = 7.2 Hz, 3 H), 1.44 (m, 2 H), 1.79 (m, 2 H), 3.20 
(s, 3 H), 4.69 (t, J = 7.6 Hz, 2 H), 8.07 (d, J = 9.2 Hz, 1 H), 8.30 (d, J = 9.2 Hz, 1 H), 8.71 (s, 1 H). 
3-ethyl-2-methylbenzo[d]thiazol-3-ium iodide, 84a: was synthesized by a similar procedure to 71c; mp 
193-195oC, 87% yield (lit mp 196oC77, 83% yield39). 
3-butyl-2-methylbenzo[d]thiazol-3-ium iodide, 84b:  was synthesized by a similar procedure to 71c; mp 
115-116oC, 94% yield (lit mp 114-115oC, 67% yield76). 
5-bromo-3-butyl-2-methylbenzo[d]thiazol-3-ium iodide, 87a was synthesized by a similar procedure to 
71c; 49% yield; 1H NMR (400 MHz, DMSO-d6): δ 0.94 (t, J = 7.2 Hz, 3 H), 1.46 (m, 2 H), 1.80 (m, 2 H), 3.22 
(s, 3 H), 4.69 (t, J = 7.6 Hz, 2 H), 7.99 (d, J = 8.8 Hz, 1 H), 8.39 (d, J = 8.8 Hz, 1 H), 8.71 (s, 1 H). 13C NMR 
(100 MHz, DMSO-d6): δ 14.01, 17.54, 19.73, 30.24, 49.80, 119.16, 121.26, 127.50, 131.50, 132.80, 
140.66, 178.50. 
6-bromo-3-butyl-2-methylbenzo[d]thiazol-3-ium iodide, 87b: was synthesized by a similar procedure to 
71c; 60% yield; 1H NMR (400 MHz, DMSO-d6): δ 0.93 (t, J = 7.2 Hz, 3 H), 1.44 (m, 2 H), 1.79 (m, 2 H), 3.20 
(s, 3 H), 4.69 (t, J = 7.6 Hz, 2 H), 8.07 (d, J = 9.2 Hz, 1 H), 8.30 (d, J = 9.2 Hz, 1 H), 8.71 (s, 1 H). 13C NMR 
(100 MHz, DMSO-d6): δ 14.01, 17.73, 19.68, 30.25, 49.76, 120.04, 123.15, 126.79, 128.93, 131.58, 
142.47, 179.06.  
3-ethyl-2-methylnaphtho[2,1-d]thiazol-3-ium iodide, 90a: was synthesized by a similar procedure to 
71c; 75% yield; 1H NMR (400 MHz, DMSO-d6): δ 1.51 (t, J = 7.2 Hz, 3 H), 3.30 (s, 3 H), 4.88 (q, J = 7.2 Hz, 2 
H), 7.87 (m, 2 H), 8.30 (d, J = 8.0 Hz, 1 H), 8.43 (m, 3 H). 
3-butyl-2-methylnaphtho[2,1-d]thiazol-3-ium iodide, 90b: was synthesized by a similar procedure to 
71c; 90% yield; 1H NMR (400 MHz, DMSO-d6): δ 0.95 (t, J = 7.2 Hz, 3 H), 1.49 (q, J = 7.2 Hz, 2 H), 1.884 
(m, 2 H), 3.31 (s, 3 H), 4.83 (t, J = 7.2 Hz, 2 H), 7.86 (m, 2 H), 8.30 (d, J = 7.6 Hz, 1 H), 8.41 (m, 3 H). 
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5.3 Unsymmetrical Trimethine Cyanine Dyes 
2,3-(3,3-dimethyl-1-(3-(trimethylammonio)propyl)indolin-2-ylidene)prop-1-en-1-yl)-1,3,3-trimethyl-
3H-indol-1-ium bromide, 74a: A mixture of 69 and 70a were heated at 100oC for one hour in acetic 
anhydride. The solution was allowed to cool to room temperature and then poured into cold diethyl 
ether. The liquid was decanted and more ether and the solid was collected by vacuum filtration. The dye 
was purified by reverse phase column chromatography (95% methanol/water). This compound was 
obtained in 54% yield; mp 188-190oC;  1H NMR (400 MHz, MeOD-d6): δ 8.59 (t, J = 13.6, 1 H), 7.52 (m, 3 
H), 7.46 (m, 2 H), 7.42 (d, J = 13.6 Hz, 1 H), 7.35 (m, 2 H), 6.89 (m, 2 H), 4.28 (t, J = 8 Hz, 2 H), 3.86 (t, J = 
8, 2 H), 3.78 (s, 3 H), 3.28 (s, 9 H), 2.36 (t, J = 7.8 Hz, 2 H), 1.81 (s, 6 H), 1.78 (s, 6 H);13C NMR (100 MHz, 
MeOD-d6): δ 176.06, 173.91, 151.16, 142.60, 141.73, 140.96, 140.57, 128.67, 128.61, 125.75, 125.11, 
122.20, 122.01, 111.25, 110.63, 104.02, 102.38, 63.02, 52.67, 49.41, 49.01, 40.40, 31.06, 27.13, 26.71, 
20.93. HRMS: Calcd for C30H41N3
2+ m/z 221.6645, obsd m/z 221.6626. 
3-(3,3-dimethyl-2-(3-(1,3,3-trimethyl-3H-indol-1-ium-2-yl)allylidene)indolin-1-yl)propane-1-sulfonate, 
74b: was synthesized by a similar procedure to 74a. The dye was purified reverse phase column 
chromatorgraphy (0.5% HCl/methanol). This compound was obtained in 38% yield; decomp 168oC; 1H 
NMR (400 MHz, MeOD-d6): δ 8.59 (t, J = 7.6 Hz, 1 H), 7.55 (d, J = 6.8 Hz, 2 H), 7.48 (t, 6.8 Hz, 3 H), 7.34 
(m, 3 H), 6.60 (d, J = 6.8 Hz, 1 H), 6.50 (d, J = 6.8 Hz, 1 H), 4.382 (t, J = 7.2 Hz, 2 H), 3.71 (s, 3 H), 3.30 (t, J 
= 6.8 Hz, 2 H), 2.27 (t, J = 7.2 Hz, 2 H), 1.78 (s, 12 H); 13C NMR (100 MHz, MeOD-d6): δ 175.42, 174.57, 
150.91, 142.71, 141.86, 140.76, 128,64, 128.53, 125.36, 125.25, 122.04, 121.93, 111.04, 110.90, 102.78, 
102.47, 49.22, 49.19, 42.57, 30.39, 26.95, 26.77, 22.75. HRMS: Calcd for C27H32N2O3S m/z 465.2167, obsd 
m/z 465.2231. 
2-(3-(1-ethyl-3,3-dimethylindolin-2-ylidene)prop-1-en-1-yl)-1,3,3-trimethyl-3H-indol-1-ium iodide, 74c:  
was synthesized by a similar procedure to 74a. The dye was purified by chromatotron (1% 
methanol/dichloromethane).  This compound was obtained in 25.6% yield; mp 139-141oC; 1H NMR (400 
53 
MHz, MeOD-d6): δ 1.44 (t, J = 7.2 Hz, 3 H), 1.78 (s, 12 H), 3.70 (s, 3 H), 4.23 (m, 2 H), 6.50 (m, 2 H), 7.33 
(t, J = 7.6 Hz, 2 H), 7.37 (d, J = 7.6 Hz, 2 H), 7.46 (t, J = 7.2 Hz, 2 H), 7.56 (m, 1 H), 7.57 (m, 1 H), 8.57 (t, J = 
13.2 Hz, 1 H); 13C NMR (100 MHz, MeOD-d6): δ 11.26, 26.79, 26.82, 30.49, 38.91, 49.18, 49.26, 102.02, 
102.37, 110.80, 110.85, 121.98, 122.18, 125.32, 125.35, 128.54, 128.62, 140.68, 140.92, 141.53, 142.70, 
150.82, 174.23, 175.23. HRMS: Calcd for C26H31N2
+ m/z 371.2487, obsd m/z 371.2473. 
2-(3-(1-butyl-3,3-dimethylindolin-2-ylidene)prop-1-en-1-yl)-1,3,3-trimethyl-3H-indol-1-ium iodide, 
74d: was synthesized by a similar procedure to 74a. The dye was purified by column chromatography 
(95% dichloromethane/methanol). This compound was obtained in 20.5% yield; mp 115-117oC; 1H NMR 
(400 MHz, MeOD-d6): δ 1.03 (t, J = 7.6 Hz, 3 H), 1.55 (m, 2 H), 1.77 (s, 12 H) 1.84 (m, 2 H), 3.72 (s, 3 H), 
4.19 (t, J = 7.6 Hz, 2 H), 6.60 (d, J = 7.2 Hz, 2 H), 7.31 (t, J = 7.2 Hz, 2 H), 7.37 (d, J = 7.6, 2 H), 7.46 (t, J = 
7.6 Hz, 2 H), 7.56 (dd, J = 6.8 Hz, 2 H), 8.55 (t, J = 6.8 Hz, 1 H); 13C NMR (MeOD-d6) δ 12.95, 19.86, 26.91, 
27.03, 29.33, 30.87, 43.90, 49.15, 49.22, 102.56, 102.70, 110.90, 111.11, 122.04, 122.19, 125.31, 128.56, 
128.61, 140.71, 140.83, 142.01, 142.70, 150.69, 174.50, 175.13. HRMS: Calcd for C28H35N2
+ m/z 
399.2795, obsd m/z 399.2810. 
2-(3-(3,3-dimethyl-1-(3-phenylpropyl)indolin-2-ylidene)prop-1-en-1-yl)-1,3,3-trimethyl-3H-indol-1-ium 
bromide, 74e: was synthesized by a similar procedure to 74a. The dye was purified by column 
chromatography (4% methanol/dichloromethane).  This compound was obtained in 60.2% yield; mp 
134-135oC; 1H NMR (400 MHz, MeOD-d6): δ 1.75 (s, 6 H), 1.77 (s, 6 H), 2.17 (m, 2 H), 2.84 (t, J = 7.6 Hz, 2 
H), 3.71 (s, 3 H), 4.16 (t, J = 7.6 Hz, 2 H), 6.21 (d, J = 13.6 Hz, 1 H), 6.29 (d, J = 13.6 Hz, 1 H), 7.22 (d, J = 8.0 
Hz, 1 H), 7.31 (m, 4 H), 7.34 (m, 3 H), 7.36 (m, 3 H), 7.48 (m, 2 H), 7.57 (t, J = 6.8 Hz, 2 H), 8.51 (t, J = 13.6 
Hz, 1 H); 13C NMR (100 MHz, MeOD-d6): δ 22.82, 26.75, 26.89, 28.53, 30.49, 32.26, 43.02, 49.22, 102.19, 
102.42, 110.87, 110.90, 121.99, 122.13, 125.32, 125.41, 126.05, 128.25, 128.31, 128.56, 140.71, 140.76, 
141.87, 142.66, 150.61, 174.41, 175.29. HRMS: Calcd for C33H37N2
+ m/z 461.2952, obsd m/z 461.2939. 
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2-(3-(5-bromo-1-butyl-3,3-dimethylindolin-2-ylidene)prop-1-en-1-yl)-1,3,3-trimethyl-3H-indol-1-ium 
iodide, 74f: was synthesized by a similar procedure to 74a. No purification was needed.  This compound 
was obtained in 86% yield; mp 141-143oC; 1H NMR (400 MHz, DMSO-d6): δ 0.94 (t, J = 7.2 Hz, 3 H), 1.41, 
(m, 2 H), 1.69 (m, 14 H), 3.68 (s, 3 H), 4.07 (t, J = 7.2 Hz, 2 H), 6.47 (d, J = 13.6 Hz, 1 H), 6.55  (d, J = 13.6 
Hz, 1 H), 7.33 (t, J = 7.2 Hz, 1 H), 7.37 (d, J = 8.4 Hz, 1 H), 7.50 (m, 2 H), 7.61 (dd, J = 6.4 Hz, 1 H), 7.65 (d, J 
= 7.2 Hz, 1 H), 7.91 (s, 1 H), 8.32 (t, J = 13.6 Hz, 1 H); 13C NMR (100 MHz, DMSO-d6): δ 14.28, 20.00, 
27.63, 27.83, 29.48, 32.11, 44.16, 49.30, 49.56, 102.64, 104.26, 112.30, 113.60, 117.61, 122.91, 126.06, 
126.21, 129.09, 131.81, 141.24, 141.88, 143.03, 143.25, 150.16, 173.24, 176.61. HRMS: Calcd for 
C28H34BrN2
+ m/z 479.1900, obsd m/z 479.1881. 
2-(3-(1-butyl-5-methoxy-3,3-dimethylindolin-2-ylidene)prop-1-en-1-yl)-1,3,3-trimethyl-3H-indol-1-ium 
iodide, 74g: was synthesized by a similar procedure to 74a. No purification was needed. This compound 
was obtained in 77% yield; mp 136-138oC; 1H NMR (400 MHz, DMSO-d6): δ 0. 94 (t, J = 7.2 Hz, 3 H), 1.40 
(m, 2 H), 1.68 (s, 6 H), 1.69 (s, 6 H), 1.69 (m, 2 H), 3.61 (s, 3 H), 3.82 (s, 3 H), 4.12 (t, J = 7.8 Hz, 2 H), 6.38 
(d, J = 13.6 Hz, 1 H), 6.47 (d, J = 13.6 Hz, 1 H), 7.00 (d, J = 8.4 Hz, 1 H), 7.26 (t, J = 7.2 Hz, 1 H), 7.32 (s, 1 
H), 7.42 (m, 3 H), 7.61 (d, J = 7.2 Hz, 1 H), 8.29 (t, J = 13.6 Hz, 2 H); 13C NMR (100 MHz, DMSO-d6): δ 
14.27, 20.01, 27.81, 27.89, 29.75, 31.62, 44.43, 48.97, 49.74, 56.37, 102.34, 103.21, 109.69, 111.51, 
113.05, 114.16, 122.81, 125.19, 128.98, 135.68, 140.76, 143.04, 143.26, 149.15, 158.57, 173.71, 173.98. 
HRMS: Calcd for C29H37N2O
+ m/z 429.2901, obsd m/z 429.2913. 
3,3-dimethyl-2-(3-(1,3,3-trimethyl-3H-indol-1-ium-2-yl)allylidene)-1-(3-
(trimethylammonio)propyl)indoline-5-sulfonate bromide, 74h: was synthesized by a similar procedure 
to 74a. The dye was purified by recrystallization in acetonitrile. This compound was obtained in 22.5% 
yield; decomp 168oC; 1H NMR (400 MHz, MeOD-d6): δ 8.59 (t, J = 1.2 Hz, 1 H), 7.91 (s, 1 H), 7.80 (d, J = 
1.2 Hz, 1 H), 7.78 (d, J = 1.2 Hz, 1 H), 7.50 (m, 3 H), 7.74 (t, J = 7.2 Hz, 1 H), 6.75 (d, J = 7.2 Hz, 1 H), 6.67 
(d, J = 7.2 Hz, 1 H), 4.24 (t, J = 7.6 Hz, 2 H), 3.79 (s, 3 H), 3.72 (t, J = 7.6 Hz, 2 H), 3.24 (s, 9H), 2.38 (m, 2 
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H), 1.80 (s, 6 H) 1.78 (s, 6 H); 13C NMR (100 MHz, MeOD-d6): δ 176.85, 173.66, 151.23, 143.25, 142.45, 
142.12, 142.12, 141.15, 140.36, 128.69, 126.83, 126.21, 122.10, 120.05, 111.62, 109.98, 104.66, 102.29, 
63.06, 52.49, 49.75, 48.80, 40.94, 31.01, 27.09, 26.54, 20.83. HRMS: Calcd for C30H40N3O3S
+ m/z 
522.2785, obsd m/z 522.2783. 
2-(-3-(3-butyl-1,1-dimethyl-1H-benzo[e]indol-2(3H)-ylidene)prop-1-en-1-yl)-1,3,3-trimethyl-3H-indol-
1-ium iodide, 74i: was synthesized by a similar procedure to 74a. No purification was needed. This 
compound was obtained in 44% yield; mp 133oC; 1H NMR (400 MHz, DMSO-d6): δ 0. 96 (t, J = 7.2 Hz, 3 
H), 1.48 (m, 2 H), 1.74 (s, 6 H), 1.78 (m, 2 H), 1.98 (s, 6 H), 3.67 (s, 3 H), 4.26 (t, J = 7.2 Hz, 2 H), 6.50 (d, J 
= 13.6 Hz, 1 H), 6.56 (d, J = 13.6 Hz, 1 H), 7.31 (m, 1 H), 7.45 (d, 2 H), 7.54 (t, J = 7.6 Hz, 1 H), 7.68 (m, 2 
H), 7.79 (d, J = 8.4 Hz, 1 H), 8.09 (m, 2 H), 8.30 (d, J = 8.4 Hz, 1 H), 8.47 (t, J = 13.6 Hz, 1 H); 13C NMR (100 
MHz, DMSO-d6): δ 0.58, 14.31, 20.02, 27.54, 27.80, 29.95, 31.82, 44.37, 49.26, 51.09, 102.51, 103.17, 
111.86, 112.24, 122.70, 122.91, 125.56, 127.86, 128.32, 129.05, 130.38, 130.93, 131.98, 133.76, 139.96, 
140.98, 143.18, 149.49, 174.56, 175.89. HRMS: Calcd for C32H37N2
+ m/z 449.2952, obsd m/z 449.2973. 
2-(3-(5-bromo-3,3-dimethyl-1-(3-(trimethylammonio)propyl)indolin-2-ylidene)prop-1-en-1-yl)-1,3,3-
trimethyl-3H-indol-1-ium bromide, 74j: was synthesized by a similar procedure to 74a. No purification 
was needed. This compound was obtained in 77% yield; mp 226oC; 1H NMR (400 MHz, DMSO-d6): δ 1.69 
(s, 6 H), 1.71 (s, 6 H), 2.13 (m, 2 H), 3.10 (s, 9 H), 3.59 (t, J = 6.8 Hz, 2 H), 3.71 (s, 3 H), 4.08 (t, J = 7.2 Hz, 2 
H), 6.68 (t, J = 12.4 Hz, 2 H), 7.36 (t, J = 7.6 Hz, 1 H), 7.47 (m, 2 H), 7.55 (d, J = 8.0 Hz, 1 H), 7.67 (t, J = 7.6 
Hz, 2 H), 7.93 (s, 1 H), 8.34 (t, J = 13.2 Hz, 1 H); 13C NMR (100 MHz, DMSO-d6): δ 21.09, 27.54, 27.92, 
32.37, 41.20, 49.16, 49.76, 53.05, 62.81, 102.58, 104.89, 112.60, 113.32, 117.50, 122.96, 126.26, 126.37, 
129.14, 131.74, 141.38, 141.70, 142.98, 143.10, 150.36, 172.76, 176.08. 
1,3,3-trimethyl-2-(-3-(3-methylbenzo[d]thiazol-2(3H)-ylidene)prop-1-en-1-yl)-3H-indol-1-ium iodide, 
75a: was synthesized by a similar procedure to 74a. No purification was needed. This compound was 
obtained in 67% yield; mp 223-225oC; 1H NMR (400 MHz, DMSO-d6): δ 1.65 (s, 6 H), 3.55 (s, 3 H), 3.94 (s, 
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3 H), 6.24 (d, J = 12.8 Hz, 1 H), 6.78 (d, J = 13.6 Hz, 1 H), 7.21 (t, J = 7.6 Hz, 1 H), 7.39 (m, 2 H), 7.51 (t, J = 
7.6 Hz, 1 H), 7.58 (d, J = 7.6 Hz, 1 H), 7.65 (t, J = 7.6 Hz, 1 H), 7.87 (d, J = 8.4 Hz, 1 H), 8.06 (m, 2 H); 13C 
NMR (100 MHz, DMSO-d6): δ 28.71, 34.51, 48.73, 99.92, 102.82, 110.96, 114.92, 122.72, 123.69, 124.54, 
125.80, 126.46, 128.78, 128.87, 140.65, 142.36, 143.40, 147.64, 168.17, 172.12. HRMS: Calcd for 
C22H23N2S
+ m/z 347.1577, obsd m/z 347.1588. 
2-(-3-(3-butylbenzo[d]oxazol-2(3H)-ylidene)prop-1-en-1-yl)-1,3,3-trimethyl-3H-indol-1-ium iodide, 
75b: was synthesized by a similar procedure to 74a. The dye was purified by chromatotron (2% 
methanol/dichloromethane).  This compound was obtained in 38% yield; mp 134oC; 1H NMR (400 MHz, 
DMSO-d6): δ 0.94 (t, J = 7.2 Hz, 3 H), 1.41 (m, 2 H), 1.66 (s, 6 H), 1.78 (m, 2 H), 3.54 (s, 3 H), 4.29 (t, J = 
7.6 Hz, 2 H), 6.23 (d, J = 13.6 Hz, 1 H), 6.41 (d, J = 13.2 Hz, 1 H), 7.21 (t, J = 7.2 Hz, 1 H), 7.34 (d, J = 7.6 Hz, 
2 H), 7.39 (t, J = 7.6 Hz, 1 H), 7.53 (m, 3 H), 7.81 (d, J = 8.0 Hz, 1 H), 7.87 (t, J = 8.0 Hz, 1 H), 8.34 (t, J = 
13.2, 1 H); 13C NMR (100 MHz, DMSO-d6): δ 14.08, 19.83, 28.42, 30.21, 44.58, 48.73, 91.17, 99.24, 
110.92, 111.92, 112.55, 122.67, 124.51, 126.38, 126.79, 128.83, 131.56, 140.61, 143.39, 147.17, 148.13, 
162.40, 172.75; HRMS: Calcd for C25H29N2O
+ m/z 373.2280, obsd m/z 373.2281. 
3-butyl-2-(-3-(1,3,3-trimethylindolin-2-ylidene)prop-1-en-1-yl)benzo[d]thiazol-3-ium iodide, 75c: was 
synthesized by a similar procedure to 74a. No purification was needed. This compound was obtained in 
86% yield; mp >250oC; 1H NMR (400 MHz, DMSO-d6): δ 0.95 (t, J = 7.2 Hz, 3 H), 1.45 (m, 2 H), 1.65 (s, 6 
H), 1.76 (m, 2 H), 3.56 (s, 3 H), 4.44 (t, J = 7.2 Hz, 2 H), 6.29 (d, J = 12.8 Hz, 1 H), 6.82 (d, J = 13.2 Hz, 1 H), 
7.22 (t, J = 7.2 Hz, 1 H), 7.39 (m, 2 H), 7.51 (t, J = 7.6 Hz, 1 H), 7.59 (d, J = 7.2 Hz, 1 H), 7.64 (t, J = 7.2 Hz, 1 
H), 7.90 (d, J = 8.4 Hz, 1 H), 8.06 (m, 2 H); 13C NMR (100 MHz, DMSO-d6): δ 14.15, 19.86, 28.73, 30.22, 
47.10, 48.78, 100.19, 102.41, 111.04, 114.86, 122.73, 123.80, 124.61, 125.94, 126.44, 128.86, 140.77, 
141.72, 143.37, 147.94, 167.67, 172.27. HRMS: Calcd for C25H29N2S
+ m/z 389.2046, obsd m/z 389.2061. 
2-(-3-(1-butylbenzo[c,d]indol-2(1H)-ylidene)prop-1-en-1-yl)-1,3,3-trimethyl-3H-indol-1-ium iodide, 
76a: was synthesized by a similar procedure to 74a. The dye was purified by column chromatography 
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(1% methanol/dichloromethane).  This compound was obtained in 79% yield; mp 128-130oC; 1H NMR 
(400 MHz, MeOD-d6): δ 1.04 (t, J = 7.6 Hz, 3 H), 1.55 (m, 2 H), 1.85 (s, 6 H), 1.89 (m, 2 H), 3.84 (s, 3 H), 
4.32 (t, J = 7.6 Hz, 2 H), 6.82 (d, J = 13.6 Hz, 1 H), 6.87 (d, J = 13.6 Hz, 1 H), 7.41 (t, J = 7.2 Hz, 1 H), 7.49 
(m, 3 H), 7.64 (d, J = 7.6 Hz, 1 H), 7.68 (d, J = 7.6 Hz, 2 H), 7.77 (d, J = 8.4 Hz, 1 H), 7.95 (t, J = 7.6 Hz, 1 H), 
8.23 (d, J = 8.4 Hz, 1 H), 8.38 (d, J = 7.2 Hz, 1 H), 8.91 (t, J = 13.6 Hz, 1 H); 13C NMR (100 MHz, MeOD-d6): 
δ 12.83, 14.03, 19.88, 27.30, 29.27, 31.06, 43.56, 65.49, 105.97, 106.89, 109.28, 111.55, 122,11, 122.52, 
125.09, 126.08, 126.61, 128.67, 129.30, 129.54, 130.29, 131.16, 141.31, 141.44, 142.58, 149.23, 155.41, 
175.92. HRMS: Calcd for C29H31N2
+ m/z 407.2482, obsd m/z 407.2499. 
1,3,3-trimethyl-2-(-3-(1-(3-(trimethylammonio)propyl)benzo[cd]indol-2(1H)-ylidene)prop-1-en-1-yl)-
3H-indol-1-ium bromide, 76b: was synthesized by a similar procedure to 74a. No purification was 
needed. This compound was obtained in 38% yield; mp 134oC; 1H NMR (400 MHz, MeOD-d6): δ 1.77 (s, 6 
H), 2.26 (m, 2 H), 3.10 (s, 9 H), 3.64 (m, 2 H), 4.33 (t, J = 6.4 Hz, 2 H), 7.05 (d, J = 13.6 Hz, 1 H), 7.12 (d, J = 
12.8 Hz, 1 H), 7.42 (t, J = 7.6 Hz, 1 H), 7.54 (t, J = 7.6 Hz, 1 H), 7.58 (d, 7.2 Hz, 1 H), 7.64 (d, J = 8.0 Hz, 1 H), 
7.72 (t, J = 6.8 Hz, 1 H), 7.76 (m, 2 H), 8.00 (t, J = 7.6 Hz, 1 H), 8.28 (d, J = 8.4 Hz, 1 H), 8.36 (d, J = 7.2 Hz, 1 
H), 8.73 (t, J = 13.6 Hz, 1 H); 13C NMR (100 MHz, MeOD-d6): δ 22.57, 28.09, 32.93, 40.93, 50.30, 52.99, 
63.01, 107.73, 108.47, 109.39, 113,17, 122.44, 123.06, 125.23, 126.93, 127.19, 129.22, 129.80, 130.09, 
130.23, 130.64, 131.41, 141.40, 142.09, 142.96, 148.87, 154.21, 176.40. HRMS: Calcd for C31H37N3
2+ m/z 
225.6488, obsd m/z 225.6170. 
2-(3-(1-butylbenzo[cd]indol-2(1H)-ylidene)prop-1-en-1-yl)-1-methylbenzo[cd]indol-1-ium bromide, 79: 
was synthesized by a similar procedure to 74a. The dye was purified by precipitation from methanol 
with ether. This compound was obtained in 41% yield; mp >260oC; 1H NMR (400 MHz, DMSO-d6): δ 0.96 
(t, J = 7.2 Hz, 3 H), 1.47 (m, 2 H), 1.83 (m, 2 H), 3.92 (s, 3 H), 4.36 (t, J = 7.2 Hz, 2 H), 7.19 (d, J = 13.2 Hz, 2 
H), 7.72 (m, 4 H), 7.86 (d, J = 7.2 Hz, 2 H), 8.05 (m, 2 H), 8.34 (d, J = 7.6 Hz, 2 H), 8.65 (d, J = 7.2 Hz, 2 H), 
9.16 (t, J = 13.2 Hz, 1 H); 13C NMR (100 MHz, DMSO-d6): δ 0.59, 14.23, 20.14, 31.28, 31.85, 44.30, 55.40, 
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111.26, 111.40, 111.50, 111.67, 124.13, 124.19, 124.66, 129.48, 129.55, 129.80, 129.89, 130.11, 130.87, 
130.92, 132.38, 141.22, 141.77, 148.51, 155.42, 156.17. HRMS: Calcd for C30H27N2
+ m/z 415.2169, obsd 
m/z 415.2172. 
3-(3-phenylpropyl)-2-(-3-(1,3,3-trimethylindolin-2-ylidene)prop-1-en-1-yl)benzo[d]thiazol-3-ium 
bromide, 82a: was synthesized by a similar procedure to 74a. The dye was purified by column 
chromatography (4% methanol/dichloromethane).  This compound was obtained in 67% yield; mp 120-
121oC; 1H NMR (400 MHz, MeOD-d6): δ 1.71 (s, 6 H), 2.24 (m, 2 H), 2.86 (t, J = 7.2 Hz, 2 H), 3.61 (s, 3 H), 
4.47 (t, J = 7.6 Hz, 2 H), 6.15 (d, J = 12.8 Hz, 1 H), 6.44 (d, J = 13.2 Hz, 1 H), 7.27 (m, 5 H), 7.36 (m, 2 H), 
7.42 (t, J = 7.6 Hz, 1 H), 7.46 (m, 2 H), 7.62 (d, J = 8.0 Hz, 2 H), 7.92 (d, J = 8.0 Hz, 1 H), 8.16 (t, J = 13.2 Hz, 
1 H); 13C NMR (100 MHz, MeOD-d6): δ 27.64, 28.81, 32.01, 45.91, 99.36, 101.26, 110.02, 113.61, 121.86, 
122.68, 124.36, 125.91, 126.12, 128.19, 128.26, 128.32, 128.37, 140.34, 141.29, 148.18, 167.74, 172.87 
HRMS: Calcd for C30H31N2S
+ m/z 451.2202, obsd m/z 451.2216. 
3-butyl-2-(-3-(1,3,3-trimethylindolin-2-ylidene)prop-1-en-1-yl)benzo[d]thiazol-3-ium iodide, 82b: was 
synthesized by a similar procedure to 74a. No purification was needed. This compound was obtained in 
86% yield; mp >250oC; 1H NMR (400 MHz, DMSO-d6): δ 0.95 (t, J = 7.2 Hz, 3 H), 1.45 (m, 2 H), 1.65 (s, 6 
H), 1.76 (m, 2 H), 3.56 (s, 3 H), 4.44 (t, J = 7.2 Hz, 2 H), 6.29 (d, J = 12.8 Hz, 1 H), 6.82 (d, J = 13.2 Hz, 1 H), 
7.22 (t, J = 7.2 Hz, 1 H), 7.39 (m, 2 H), 7.51 (t, J = 7.6 Hz, 1 H), 7.59 (d, J = 7.2 Hz, 1 H), 7.64 (t, J = 7.2 Hz, 1 
H), 7.90 (d, J = 8.4 Hz, 1 H), 8.06 (m, 2 H); 13C NMR (100 MHz, DMSO-d6): δ 14.15, 19.86, 28.73, 30.22, 
47.10, 48.78, 100.19, 102.41, 111.04, 114.86, 122.73, 123.80, 124.61, 125.94, 126.44, 128.86, 140.77, 
141.72, 143.37, 147.94, 167.67, 172.27. HRMS: Calcd for C25H29N2S
+ m/z 389.2046, obsd m/z 389.2061. 
6-bromo-3-butyl-2-(3-(1,3,3-trimethylindolin-2-ylidene)prop-1-en-1-yl)benzo[d]thiazol-3-ium iodide, 
82c: was synthesized by a similar procedure to 74a. No purification was needed. This compound was 
obtained in 85% yield; mp >260 oC; 1H NMR (400 MHz, DMSO-d6): δ 0.94 (t, J = 7.2 Hz, 3 H), 1.43 (m, 2 H), 
1.65 (s, 6 H), 1.71 (m, 2 H), 3.58 (s, 3 H), 4.39 (t, J = 7.2 Hz, 2 H), 6.34 (d, J = 13.2 Hz, 1 H), 6.78 (d, J = 12.8 
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Hz, 1 H), 7.25 (t, J = 6.8 Hz, 1 H), 7.41 (m, 2 H), 7.60 (d, J = 7.2 Hz, 1 H), 7.81 (m, 2 H), 8.02 (t, J = 13.2 Hz, 
1 H), 8.32 (s, 1 H); 13C NMR (100 MHz, DMSO-d6): δ 14.16, 19.81, 28.63, 30.07, 47.14, 49.00, 100.87, 
102.06, 111.35, 116.28, 118.25, 122.76, 124.95, 126.05, 127.96, 128.92, 131.57, 140.93, 141.21, 143.27, 
148.30, 167.18, 172.97. HRMS: Calcd for C25H28BrN2S
+ m/z 467.1151, obsd m/z 467.1149. 
3-ethyl-2-(3-(3-ethylbenzo[d]thiazol-2(3H)-ylidene)prop-1-en-1-yl)benzo[d]thiazol-3-ium iodide, 85a:  
Quaternary ammonium salt 84a and triethyl orthoformate were heated in acetic anhydride for 2 hours. 
The solution was allowed to cool to room temperature and poured into ether. The ether was decanted 
and more ether was added three times before the solid was filtered. No purification was needed. This 
compound was obtained in 72% yield; mp >260oC (lit mp 267-269oC, 86% yield78);  1H NMR (400 MHz, 
DMSO-d6): δ 1.35 (t, J = 6.8 Hz, 6 H), 4.39 (d, J = 6.8 Hz, 4 H), 6.63 (d, J = 13.2 Hz, 2 H), 7.43 (t, J = 7.6 Hz, 
2 H), 7.58 (t, J = 8.0 Hz, 2 H), 7.80 (m, 3 H), 8.01 (d, J = 7.6 Hz, 2 H); 13C NMR (100 MHz, DMSO-d6): δ 
13.08, 21.53, 41.94, 99.10, 113.84, 123.59, 125.67, 128.59, 141.27, 147.13, 164.64. 
3-butyl-2-(3-(3-butylbenzo[d]thiazol-2(3H)-ylidene)prop-1-en-1-yl)benzo[d]thiazol-3-ium iodide 85b: 
was synthesized by a similar procedure to 85a. No purification was needed. This compound was 
obtained in 66% yield; mp >260oC (lit mp 283-284oC79);  1H NMR (400 MHz, DMSO-d6): δ 0.94 (t, J = 7.2 
Hz, 6 H), 1.43 (m, 4 H), 1.72 (m, 4 H), 4.34 (t, J = 7.2 Hz, 4 H), 6.62 (d, J = 12.8 Hz, 2 H), 7.43 (t, J = 7.6 Hz, 
2 H), 7.58 (t, J = 7.6 Hz, 2 H), 7.78 (m, 3 H), 8.00 (d, J = 7.6 Hz 2 H); 13C NMR (100 MHz, DMSO-d6): δ 
13.70, 19.41, 29.44, 46.08, 98.78, 113.64, 123.06, 125.22, 128.08, 139.48, 141.26, 146.68, 164.62. 
3-(3-phenylpropyl)-2-(3-(3-(3-phenylpropyl)benzo[d]thiazol-2(3H)-ylidene)prop-1-en-1-
yl)benzo[d]thiazol-3-ium iodide 85c:  was synthesized by a similar procedure to 85a. No purification was 
needed. This compound was obtained in 67% yield; mp 220-221oC;  1H NMR (400 MHz, DMSO-d6): δ 
2.09 (t, J = 7.2 Hz, 4 H), 2.79 (m, 4 H), 4.38 (t, J = 7.2 Hz, 4 H), 6.43 (d, J = 12.0 Hz, 2 H), 7.26 (m, 12 H), 
7.56 (t, J =6.8 Hz, 2 H), 7.69 (d, J = 7.2 Hz, 2 H), 7.76 (t, J = 12.8 Hz, 1 H), 7.99 (d, J = 7.2 Hz, 2 H); 13C NMR 
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(100 MHz, DMSO-d6): δ 28.57, 31.78, 45.82, 113.37, 122.89, 125.09, 125.94, 127.91, 128.05, 128.25, 
140.51, 141.07. HRMS: Calcd for C35H33N2S2
+ m/z 545.2080, obsd m/z 545.2061. 
5-bromo-2-(3-(5-bromo-3-butylbenzo[d]thiazol-2(3H)-ylidene)prop-1-en-1-yl)-3-butylbenzo[d]thiazol-
3-ium iodide, 88a: was synthesized by a similar procedure to 85a. No purification was needed. This 
compound was obtained in 77% yield; mp >260oC;   1H NMR (400 MHz, DMSO-d6): δ 0.94 (t, J = 7.2 Hz, 6 
H), 1.43 (m, 4 H), 1.69 (m, 4 H), 4.33 (t, J = 7.2 Hz, 4 H), 6.63 (d, J = 12.8 Hz, 2 H), 7.60 (d, J = 8.4 Hz, 2 H), 
7.79 (t, J = 12.8 Hz, 1 H), 7.95 (d, J = 8.4 Hz, 2 H), 8.08 (s, 2 H);13C NMR (100 MHz, DMSO-d6): δ 0.56, 
14.20, 19.78, 29.91, 46.70, 100.02, 116.78, 121.59, 125.06, 125.10, 128.43, 143.14, 147.65. HRMS: Calcd 
for C25H27Br2N2S2
+ m/z 576.9977, obsd m/z 576.9983. 
6-bromo-2-(3-(6-bromo-3-butylbenzo[d]thiazol-2(3H)-ylidene)prop-1-en-1-yl)-3-butylbenzo[d]thiazol-
3-ium iodide, 88b: was synthesized by a similar procedure to 88a. This compound was obtained in 76% 
yield; mp >260oC; 1H NMR (400 MHz, DMSO-d6): δ 0.93 (t, J = 7.2 Hz, 6 H), 1.42 (m, 4 H), 1.69 (m, 4 H), 
4.31 (t, J = 7.2 Hz, 4 H), 6.62 (d, J = 12.8 Hz, 2 H), 7.77 (m, 5 H), 8.28 (s, 2 H);13C NMR (100 MHz, DMSO-
d6): δ 14.15, 19.83, 29.85, 46.80, 99.84, 115.73, 117.63, 125.91, 127.77, 131.34, 141.20, 147.52, 165.24.  
HRMS: Calcd for C25H27Br2N2S2
+ m/z 576.9977, obsd m/z 576.9983. 
3-ethyl-2-(3-(3-ethylnaphtho[2,1-d]thiazol-2(3H)-ylidene)prop-1-en-1-yl)naphtho[2,1-d]thiazol-3-ium 
iodide, 91a: was synthesized by a similar procedure to 88a. The dye was purified by chromatotron (4% 
methanol/dichloromethane). This compound was obtained in 70% yield; mp >260 oC;  1H NMR (400 MHz, 
DMSO-d6): δ 1.40 (t, J = 6.4 Hz, 6 H), 4.47 (q, J = 6.0 Hz, 4 H), 6.67 (d, J = 12.4 Hz, 2 H), 7.55 (t, J = 7.6 Hz, 
2 H), 7.93 (m, 5 H), 8.06 (d, J = 7.2 Hz, 2 H), 8.14 (d, J = 7.6 Hz, 2 H);13C NMR (100 MHz, DMSO-d6): δ 
13.47, 42.43, 99.21, 113.18, 121.40, 123.52, 126.75, 127.00, 129.07, 129.59, 129.93, 130.64, 139.39, 
145.86, 163.44. HRMS: Calcd for C29H25N2S2
+ m/z 465.1454, obsd m/z 465.1455. 
3-butyl-2-(3-(3-butylnaphtho[2,1-d]thiazol-2(3H)-ylidene)prop-1-en-1-yl)naphtho[2,1-d]thiazol-3-ium 
iodide, 91b: was synthesized by a similar procedure to 88a. No purification was needed. This compound 
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was obtained in 60% yield; mp >260oC;  1H NMR (400 MHz, DMSO-d6): δ 0.96 (t, J = 7.2 Hz, 6 H), 1.47 (m, 
4 H), 1.78 (m, 4 H), 4.45 (t, J = 7.2 Hz, 4 H), 6.69 (d, J = 12.8 Hz, 2 H), 7.61 (t, J = 8.0 Hz, 2 H), 7.74 (t, J = 
8.0 Hz, 2 H), 7.93 (m, 5 H), 8.10 (d, J = 8.0 Hz, 2 H), 8.16 (d, J = 9.2 Hz, 2 H);13C NMR (100 MHz, DMSO-
d6): δ 14.22, 19.88, 30.28, 47.00, 99.44, 113.48, 121.30, 123.59, 126.71, 127.11, 129.15, 129.65, 129.88, 
130.65, 139.86, 145.96, 163.86. HRMS: Calcd for C33H33N2S2
+ m/z 521.2080, obsd m/z 521.2075. 
3-(3-phenylpropyl)-2-(3-(3-(3-phenylpropyl)naphtho[2,1-d]thiazol-2(3H)-ylidene)prop-1-en-1-
yl)naphtho[2,1-d]thiazol-3-ium bromide, 91c: was synthesized by a similar procedure to 88a. No 
purification was needed. This compound was obtained in 50% yield; mp 231-233oC;  1H NMR (400 MHz, 
DMSO-d6): δ 2.15 (m, 4 H), 2.82 (m, 4 H), 4.515 (m, 4 H), 6.52 (d, J = 12.4 Hz, 2 H), 7.21 (m, 2 H), 7.28 (m, 
7 H), 7.64 (t, J = 7.6 Hz, 2 H), 7.76 (t, J = 7.6 Hz, 2 H), 7.92 (m, 3 H), 8.00 (d, J = 8.0 Hz, 2 H), 8.15 (t, J = 9.6 
Hz, 4 H);13C NMR (100 MHz, DMSO-d6): δ 29.60, 32.34, 46.82, 113.39, 121.42, 123.60, 126.59, 126.74, 
127.16, 128.70, 128.90, 129.19, 129.69, 129.88, 130.69, 139.86, 141.18, 145.94. HRMS: Calcd for 
C43H37N2S2
+ m/z 645.2393, obsd m/z 645.2375. 
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